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ABSTRACT 
 
Dissertation Advisor: Dr. Wolfram Goessling             Maija Kristine Garnaas 
 
 
 
The Role of Nuclear Receptor Signaling in Vertebrate Liver Development 
 
 
Proper embryonic development requires precise genetic regulation of cell growth 
and differentiation.  Organogenesis, the origin and formation of internal organs, must be 
exquisitely choreographed to ensure correct temporal and spatial patterning of functional 
organs within the developing organism.  The liver is a vital organ responsible for 
hundreds of essential metabolic functions, but the intricate pathways controlling organ 
specification, differentiation, and positioning have not been fully elucidated.  Uncovering 
the molecular mechanisms involved in hepatogenesis will enhance our understanding of 
normal liver development as well as inform the design of therapeutics to combat liver 
disease.  Nuclear receptors are evolutionarily recent signal transducers that occupy a 
special niche in gene regulation, acting as direct connections between a ligand and its 
downstream transcriptional target.  Nuclear receptor signaling governs many 
physiological processes, however its impact on liver development is not well understood. 
 In this dissertation, I explore the functions of two nuclear receptor signaling 
pathways in embryonic zebrafish liver development.  First, I define the role of retinoic 
acid signaling during liver specification.  Retinoic acid positively impacts liver 
development, and individual retinoic acid receptors (RARs) exert distinct effects on 
hepatic specification.  One receptor, Rargb, is uniquely responsible for positioning the 
liver along the left-right axis and functions upstream of BMP signaling to regulate organ 
sidedness.  Loss of Rargb results in an embryonic phenotype reminiscent of the human 
heterotaxic condition right atrial isomerism, or Ivemark Syndrome.   
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 Second, I delineate the impact of physiological and environmental estrogens on 
hepatic differentiation.  Estrogenic compounds negatively regulate liver development and 
exert their effect through estrogen receptor 2 (ESR2) isoforms.  In particular, estrogen 
exposure prevents hepatic differentiation, and embryonic estrogen production and 
response are carefully orchestrated to enable timely liver maturation.  This effect is 
conserved across vertebrate species. 
 Together, these studies provide novel insight into the function of nuclear receptor 
signaling during embryonic liver development.  Continued investigation into 
transcriptional regulation of hepatic specification and differentiation will expand our 
understanding of and engender new therapies for liver dysfunction. 
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DEVELOPMENTAL BIOLOGY PROVIDES INSIGHT INTO HUMAN DISEASE  
Developmental biology is defined as the study of the mechanisms by which 
organisms grow and develop.  The process of converting a single cell to tissues, organs, 
and ultimately a viable organism consists of a sequence of remarkable and complex 
events.  In the words of developmental biologist Scott Gilbert, "…forming an embryo is 
the hardest thing you will ever do… One of the critical differences between you and a 
machine is that a machine is never required to function until after it is built.  Every animal 
has to function as it builds itself" (Gilbert, 2008).  Development is intricately controlled by 
a series of transcriptional cascades.  Strict temporal and spatial control of gene 
expression drives cell specification, differentiation, and proliferation, all of which are 
imperative for proper development.    
Investigating how individual organs develop (organogenesis) is extraordinarily 
useful for understanding human biology and pathology.  Uncovering the mechanisms by 
which development unfolds and homeostasis is achieved not only provides us with an 
encyclopedia of knowledge of the requisite elements but also provides the foundation for 
understanding aberrations that contribute to a variety of disease states.  Identifying the 
molecular players involved in development most obviously impacts our understanding of 
developmental abnormalities such as congenital organ defects, however its utility goes 
beyond the embryo.  In many adult disease states, cells or entire organs improperly 
reactivate genetic pathways used during development to their detriment.  Cells’ improper 
activation of and failure to turn off proliferative signals is a hallmark of many cancers.  
Our ability to recognize these signals as repurposed from the developmental setting is 
integral to the production of successful therapies.   
Similarly, understanding developmental signaling will also allow us to harness its 
advantageous aspects for use as medical treatment.  For example, a number of genes 
are normally only expressed during embryonic or fetal life in progenitor cells, which are 
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responsible for populating organ primordia and setting in motion differentiation cascades 
that ultimately lead to the generation of multiple cell types and a complex organ.  If 
recycled in a highly controlled manner in the adult, these cellular signals may aid in 
regenerating damaged tissues that may otherwise be incapable of naturally repairing 
themselves.  Indeed, investigations of developmental genes are often couched within the 
development-cancer-regeneration trilogy and for good reason.   Development is driven 
by hundreds of elaborate signaling pathways that work in concert to create a fully 
functional embryo.  Understanding these processes in the complicated developmental 
milieu can only further our comprehension of their effect in the adult, whether they 
reappear during disease or are intentionally applied for therapeutic purposes. 
 
THE ZEBRAFISH MODEL 
Model organisms, non-human species used to study biological phenomena, are 
the workhorses of developmental biology.  Where human research is not feasible or 
considered unethical, in vivo animal models provide a useful proxy for understanding 
early developmental events.  There are a number of model organisms in use today – 
prokaryotes, fungi, invertebrates, and vertebrates – and each offers particular 
advantages.  Vertebrate animals, closest evolutionarily to humans, are well suited for 
studies on organ development.  The zebrafish (Danio rerio) has emerged as one of the 
most powerful models to investigate early development, and it is the backbone of this 
thesis.  
 The zebrafish emerged as a house pet cum highly tractable genetic organism in the 
1980s when George Streisinger, considered the founding father of zebrafish genetics, 
published a study in which he described the generation of homozygous diploid zebrafish 
to facilitate mutant isolation and analysis (Streisinger et al., 1981).  The following 
decade, Christiane Nüsslein-Volhard and Wolfgang Driever pioneered a number of 
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genome-wide mutagenesis screens, uncovering a slew of genes responsible for a range 
of embryonic phenotypes as well as mutations resulting in organ defects reminiscent of 
human pathologies (Driever et al., 1996; Haffter et al., 1996; Kane et al., 1996).  
Importantly, these studies demonstrated that effective large-scale genetic screens could 
be conducted in vertebrates, not just flies and worms.  As a model, the advantages of 
the zebrafish are many.  71.4% of human genes have a zebrafish ortholog, and 82% of 
human genes associated with human morbidity have a zebrafish ortholog (Howe et al., 
2013).  As such, the zebrafish has been used successfully to elucidate the mechanism 
of a number of human diseases (Lieschke and Currie, 2007).  Zebrafish embryos are 
externally fertilized and optically transparent, allowing for direct observation, and they 
exhibit high fecundity (a single mating pair can produce 300 embryos a week) and 
develop rapidly (the heart starts to beat at 1 day post-fertilization).  Furthermore, 
zebrafish are highly amenable to chemical and genetic manipulation (Kari et al., 2007; 
Zon and Peterson, 2005).  As a case in point, our laboratory conducted a chemical 
genetic screen using zebrafish embryos, testing roughly 2,600 bioactive compounds for 
their effects on organogenesis, and two hits from this screen are the bases for Chapters 
2 and 3 of this thesis. 
 
THE LIVER 
Human liver 
The liver is an essential organ responsible for a number of metabolic, endocrine, 
and exocrine functions.  It plays vital roles in nutrient processing, including glycogen 
storage and cholesterol synthesis and transport, blood detoxification, and secretion of 
serum proteins and bile.  The liver is primarily composed of hepatoctyes – they make up 
three-quarters of its volume – which function in concert with a number of other cell types 
including biliary epithelial cells (cholangiocytes), endothelial cells, Kupffer cells 
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(macrophages), and hepatic stellate cells.  The liver lobule is the basic architectural unit 
of the liver and consists of hexagonal plates of hepatocytes (Figure 1-1).  Portal triads, 
each containing a hepatic artery, portal vein, and bile duct, border each of the six 
corners of the lobule.  Blood enters the lobule via the hepatic artery and portal vein, 
supplying oxygen and nutrients to the organ, and then flows through a network of 
sinusoidal capillaries before it leaves through the central vein located at the lobule’s 
middle.   Bile generated by hepatocytes is collected first into bile caniculi then drained 
into bile ducts where it is either secreted into the small intestine or stored in the gall 
bladder. 
Altered liver function resulting from developmental defects, inflammation, 
cirrhosis, or cancer leads to significant morbidity and mortality, however treatment 
options for these conditions remain extremely limited.  It is estimated that one in every 
ten Americans suffers from liver disease, and liver disease in one of the top ten causes 
of death in the United States.  Liver transplant is the only long-term option for treating 
advanced liver failure, however there is a great disparity between the number of patients 
requiring transplant and the number of available organs.  In the United States, 6,000 
liver transplants are performed annually while nearly 17,000 patients remain on the 
waiting list (American Liver Foundation, 2013).  Continued investigations into the 
molecular mechanisms responsible for hepatic specification will engender new and 
better therapies to combat liver dysfunction. 
 
Liver development in terrestrial vertebrates  
 Endoderm, one of the three primary germ layers, is established during 
gastrulation, and the liver arises from the anterior portion of the primitive gut tube, or 
foregut endoderm (Le Douarin, 1975) (Figure 1-2A).  Cell fate-mapping studies have  
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Figure 1-1.  Human liver architecture. 
(A) Schematic depicting the arrangement of the liver (red), gall bladder (green), and 
stomach and intestine (yellow) in the adult.  Bile secreted by the liver is collected by a 
network of intrahepatic ducts (hd) and drained from the liver into the common hepatic 
duct (chd).  From there, bile enters the gall bladder via the cystic duct (cd) or the 
duodenum via the common bile duct (cbd), where it facilitates digestion. 
(B) Schematic illustrating the cellular architecture of the liver.  The primary functional unit 
of the liver comprises a hexagonal sheet of hepatocytes containing a central vein and 
portal triad consisting of a bile duct, portal vein, and hepatic artery.  Taken from Zorn, 
2008. 
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Figure 1-2 (next page).  Vertebrate liver development. 
(A) In the mouse, the liver (red) is derived from the foregut endoderm (fg, yellow), and 
hepatic progenitors are first identifiable by gene expression at e8.  Specified 
hepatoblasts bud into the surrounding mesencyme forming the liver diverticulum (ld), 
and as the liver continues to grow outwardly, it ultimately forms a distinct liver bud (lb).  
By e15, hepatoblasts have begun differentiating into hepatocyte and biliary lineages, and 
the liver continues to mature after birth. 
(B-F) Zebrafish liver development.  Hepatic progenitors are specified in the gut tube by 
24 hpf (B), and the liver bud emerges to the left of the midline between 24-28 hpf 
(arrowhead, C).  The newly formed liver bud continues to expand outwardly from 48 hpf 
onward (D, E), and a furrow forms to separate the liver from the intestinal bulb (black 
arrow).  The pancreas also emerges from the foregut endoderm at this time (asterisks in 
C, D).  By 5 dpf, the liver (red) lies ventral and anterior to the swim bladder (sb) and 
notochord (n), with one lobe sitting atop the head of the pancreas (green).  At this point 
in development, the liver has formed bilateral (left and right) lobes.  Images in (B-D) are 
dorsal views of foxA3:GFP transgenic reporter fish.  (E) depicts expression of the 
hepatocyte marker lfabp.  Adapted from Field et al., 2003; Zorn, 2008; Tao and Peng, 
2009; Chu and Sadler, 2009. 
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Figure 1-2 (continued) 
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established that liver progenitors originate in three separate domains within the 
developing foregut (Tremblay and Zaret, 2005).  Upon foregut closure, the bilateral and 
medial domains merge, and the hepatic endoderm is specified.  The first morphological 
indicator of liver specification is an out-pocketing of foregut epithelium known as the liver 
diverticulum.  The anterior region of the diverticulum ultimately generates the liver and 
intrahepatic bileducts, whereas the posterior portion forms the gall bladder and 
extrahpatic bile ducts (Zorn, 2008; Si-Tayeb et al., 2010). 
As hepatic progenitor cells bud into the surrounding stroma, they receive 
instructive signals from neighboring tissues (Le Douarin, 1975; Cascio and Zaret, 1991).  
Fibroblast growth factor (Fgf) and bone morphogenetic protein (Bmp) signals generated 
by adjacent pre-cardiac mesoderm and septum transversum mesenchyme (STM), 
respectively, induce hepatic progenitors (hepatoblasts) and promote outgrowth of the 
liver primordium (Jung et al., 1999; Rossi et al., 2001). Secreted Fgfs also suppress the 
default pancreatic fate of the ventral endoderm (Deutsch et al., 2001).  Following 
specification of the hepatic endoderm, the earliest known marker of the developing liver 
is hematopoietically-expressed homeobox protein (Hhex), a homeodomain transcription 
factor.  Loss of Hhex results in failed liver bud outgrowth, however expression of liver-
specific genes and a slight swelling of the endoderm are still detectable (Keng et al., 
2000; Martinez Barbera et al., 2000), suggesting that specification of the hepatic lineage 
still occurs in Hhex null mice.  Hhex and another homeodomain transcription factor, 
Prospero homeobox protein 1 (Prox1), also regulate hepatic differentiation and 
proliferation (Sosa-Pineda et al., 2000).  Members of the hepatic nuclear factor (Hnf), 
GATA-binding factor (Gata), and forkhead box A (FoxA) families of transcription factors 
direct hepatic specification and coordinate subsequent differentiation of hepatoblasts 
into mature hepatocyte and bile-duct lineages (Zaret, 2002), while wingless-type MMTV 
integration site family member (Wnt) signaling modulates expansion of the hepatocyte 
	   10	  
population (Thompson and Monga, 2007).  
 
Liver development in zebrafish 
            The zebrafish (Danio rerio) is an excellent model for the study of vertebrate 
organogenesis.  Embryos develop ex utero, are optically clear, and hundreds of embryos 
can be produced weekly for large-scale genetic manipulations or chemical screens.  In 
addition, the zebrafish is uniquely suited for studying liver development because the liver 
is not a site of hematopoiesis as it is in mice (Davidson and Zon, 2004), allowing for 
investigation of liver defects without complications from anemia or early lethality. 
            In the fish, hepatic progenitors are first identifiable by hhex expression at 18 
hours post fertilization (hpf) in the anterior endoderm.  Between 24 and 28 hpf, 
hepatoblasts aggregate and emerge as a bud to the left of the midline (Figure 1-2, B-C) 
(Field et al., 2003).  By 48 hpf, the liver begins to function, and specified hepatocytes 
express mature markers such as liver fatty acid binding protein (lfabp) (Figure 1-2, D-E) 
(Her et al., 2003).  At this stage, a furrow also forms to separate the liver bud from the 
intestine, and the remaining cells connecting these organs form the hepatic duct.  As in 
mice, this initial budding phase is characterized by expression of a number of foxA and 
gata factors, as well as hhex, prox1, and hnf4 in the liver primordium (Field et al., 2003).  
Subsequent outgrowth of the liver bud is driven by accelerated hepatocyte proliferation.  
The mature liver is bi-lobed and consists of a larger left lobe that lies adjacent to the 
anterior gut and a smaller right lobe that abuts the head of the pancreas (Figure 1-2F) 
(Chu and Sadler, 2009). 
Importantly, the molecular programs governing liver development are conserved 
among vertebrates (Stainier, 2002; Zorn and Wells, 2007).  Expression of dominant 
negative forms of Fgf and Bmp receptors following heat shock induction revealed that 
Bmp and Fgf signals are required during hepatoblast specification (18-22 hpf), but are 
	   11	  
largely dispensable for maintenance of specified liver progenitors (Shin et al., 2007).  
Furthermore, expression of Fgf and Bmp signals in the surrounding mesoderm prevents 
specification of pancreatic lineages (Chung et al., 2008; Dong et al., 2007).  Hepatic 
specification is defective in prometheus/wnt2bb and adenomatous polyposis coli (APC) 
mutants (Goessling et al., 2008; Ober et al., 2006), also demonstrating a conserved 
requirement for Wnt signaling during hepatogenesis.   
 Given that precursors of many endodermal organs derive along the anterior-
posterior axis of the digestive tract, it is not surprising that multiple signaling inputs are 
required to specify the liver primordium.  What makes one endodermal domain 
competent to interpret and translate these signals into the hepatic fate remains one of 
the outstanding questions in the field of liver development.  Identifying additional liver-
specific signals and elucidating their regulation in space and time will advance our 
understanding of hepatic development and homeostasis. 
 
NUCLEAR RECEPTOR SIGNALING  
 Nuclear receptors (NRs) are defined as ligand-activated transcription factors that 
bind to and thereby regulate downstream gene targets.  NRs are organized in a modular 
fashion, containing five to six functional domains that are designated A-E/F (Figure 1-3A) 
(Renaud and Moras, 2000).  Each domain is relatively autonomous such that 
exchanging the same domain among related NRs does not significantly impact NR 
function (Aranda and Pascual, 2001).  The two most highly conserved domains are the 
DNA-binding domain (DBD) (C) and ligand-binding domain (LBD) (E), which mediate 
NR's ability to activate transcription.  The DBD is located nearer the N-terminus and 
contains two zinc-finger motifs, whereas the LBD is located closer to the C-terminus and 
is composed of a series of alpha helices.  The A and F domains flanking these regions 
are highly variable and often contain an autonomous (ligand-independent) transcriptional  
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Figure 1-3.  Nuclear receptor structure and signaling. 
(A) Nuclear receptors typically consist of five to six functional domains: a variable N-
terminal domain A/B, a DNA binding domain C, a hinge domain D, a ligand binding 
domain E, and a variable C-terminal domain F. 
(B) Nuclear receptor signal transduction is initiated when ligands such as retinoids or 
steroid hormones bind to the ligand binding domain (LBD) of their associated nuclear 
receptors.  Receptors may either homo- or heterodimerize and bind to downstream 
transcriptional targets via their DNA binding domain (DBD).  In the case of retinoic acid 
receptors (RARs), receptors are situated on the promoter of the target gene, and ligand 
binding causes release of a corepressor complex allowing for transcription to proceed.  
Estrogen receptors (ERs) are normally localized to the cytoplasm but translocate to the 
nucleus following ligand activation.  Adapted from Handschin and Meyer, 2003. 
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activation function termed AF-1.  A second transcriptional activation domain is found in 
the LBD/E domain, however it is strictly ligand-dependent.  NRs are primarily activated 
by lipophilic molecules such as steroid hormones, vitamin derivatives, and fatty acids; 
the alpha helices in the LBD create a hydrophobic pocket that has high affinity for these 
lipophilic ligands. 
The NR superfamily is subdivided into three classes – the steroid, 
thyroid/retinoid, and orphan receptor families (Cheskis, 2004; Robinson-Rechavi et al., 
2003; Tata, 2002).  Steroid receptors include the estrogen receptor (ER), androgen 
receptor (AR), progesterone receptor (PR), glucocorticoid receptor (GR), and 
mineralocorticoid receptor (MR).  Typically, inactive steroid receptors are bound to heat 
shock proteins (Hsp) in the cytoplasm.  Following ligand binding, steroid receptors are 
released from the Hsp complex, homodimerize, and translocate to the nucleus to bind to 
NR response elements on target gene promoters (Figure 1-3B).  Thyroid/retinoid 
receptors include the vitamin D receptor (VDR), retinoic acid receptor (RAR), thyroid 
receptor (TR), and peroxisome proliferator-activated receptor (PPAR).  In contrast to the 
steroid receptor subclass, thyroid/retinoid receptors generally function as heterodimers 
in complex with retinoid X receptors (RXR).  Moreover, these receptor heterodimers 
function as gene silencers in the absence of ligand via recruitment of co-repressors such 
as the nuclear co-repressor (NCoR) and silencing mediator for retinoic acid and thyroid 
hormone receptors (SMRT) (Collingwood et al., 1999; Smirnov, 2002).  Ligand binding 
alleviates this repression, allowing for target activation.   
To date, 48 members have been identified in the NR superfamily in humans (Imai 
et al., 2013).  There are more NR paralogs in zebrafish than mammals due to a genome 
duplication event during teleost evolution (Postlethwait et al., 1998).  Phylogenetically, all 
NRs share a common ancestor, and it is hypothesized that NRs originated as orphan 
receptors.  Lines of evidence supporting this theory include the fact that orthologs of 
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classically liganded receptors have not been identified in non-bilaterian animals 
(suggesting a more recent evolution of the liganded NRs), and NRs can elicit cellular 
responses independent of ligand activation, for example by conformational changes 
mediated by phosphorylation (Markov and Laudet, 2011).  It is widely believed that 
ancestral NRs originally acted as environment and nutrient sensors since their existence 
well preceded the development of any endocrine system.  There is remarkable similarity 
between the xenobiotic response and steroid metabolism pathways, as both make use 
of the cytochrome P450 (Cyp) hydroxylating enzymes.  This suggests that dietary 
metabolites such as steroids derived from cholesterol or retinoids derived from β-
carotene may have at one point acted as endogenous hormones (Khersonsky et al., 
2006).  By using NRs to sense environmental toxins or internal nutrient levels, an 
organism may have thereby appropriately regulated production of necessary 
detoxification enzymes.  Certainly, the evolution of animals and NR signaling occurred in 
parallel, as the development of additional and more complex NR-ligand pairs allowed for 
regulation between organ systems in more complex organisms.  In fact, there is strong 
correlation between the number and kinds of cell types in an animal and the number of 
NR genes (Escriva et al., 2004; Escriva et al., 2000). 
Continued investigation of the impact of NRs on embryonic development will 
undoubtedly aid in the creation of effective human therapies.  NRs are attractive drug 
targets not only because they play integral roles in a host of development processes but 
because their activity is ligand-dependent, and many of the most effective clinical 
treatments consist of small hydrophobic compounds that can easily traverse a cell's 
plasma membrane to exert their effect. 
 
Retinoic acid signaling            
            Retinoic acid (RA) is the active form of vitamin A (retinol).  Vitamin A is an 
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essential nutrient that requires strict regulation during embryonic development, as 
vitamin A deficiency results in congenital malformations in heart, eye, circulatory, 
urogenital, and respiratory systems, and excessive vitamin A is teratogenic (Zile, 1998).  
RA exerts its effects on embryogenesis by regulating gene expression.  However, unlike 
protein factors such as Fgf or Wnt that bind to cell surface receptors, RA acts directly on 
target genes in the nucleus via its receptors.  Retinol, transported in the serum by 
retinol-binding protein 4 (Rbp4) to RA-generating tissue, is first converted to 
retinaldehyde by alcohol or retinol dehydrogenases (Adh or Rdh) then is further 
converted to RA by retinaldehyde dehydrogenases (Raldh).  Adhs are widely expressed 
whereas Raldhs show tissue-specific expression (Duester, 2008; Liang et al., 2008).  
Spatial regulation of RA is further achieved by Cyp enzymes, which are responsible for 
degrading RA (White and Schilling, 2008), and cellular RA-binding proteins (Crabp), 
which facilitate RA uptake (Sessler and Noy, 2005).  Once RA enters its target cell, it 
can bind to two types of retinoid receptors – the RA receptors (RARs) and retinoid X 
receptors (RXRs) – both of which are part of the NR superfamily (Pfahl and Chytil, 
1996).  In mammals, there are three orthologs of both RARs and RXRs (α, β, γ), and 
multiple isoforms of each RAR perform varied functions (Bastien and Rochette-Egly, 
2004).  Zebrafish possess all RXR subtypes but only RARα and γ orthologs.  RARs bind 
all-trans-RA (ATRA), and RXRs bind its less common isomer 9-cis-RA.  RXRs are 
known to heterodimerize with RARs, however ligand binding to the RAR component of 
heterodimers is sufficient for signal transduction in mice (Mic et al., 2003).  Coupling of 
the ligand-receptor complex with a RA reponse element (RARE) on a target gene's 
promoter mediates transcription. 
 
Estrogen signaling 
 Estrogen is a steroid hormone that plays a critical role in many aspects of human 
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physiology.  Estrogen signaling is known to impact reproductive development and 
function, tissue growth, bone maintenance, and the cardiovascular, nervous, and 
immune systems.  Not surprisingly, estrogen excess or deficiency has been linked to a 
number of diseases, including breast and prostate cancer, osteoporosis, and infertility 
(Heldring et al., 2007).  Estrogen is a cholesterol derivative that is sequentially converted 
from progestagens to androgens and finally estrogens through a series of enzymatic 
reactions.  The final rate-limiting step in estrogen biosynthesis is catalyzed by the Cyp 
enzyme aromatase (Cyp19a1).  There are three naturally occurring estrogens – estriol, 
estradiol, and estrone – which bind to estrogen receptors (ERs) with differing affinities.  
Estradiol is the most potent circulating estrogen.  To initiate signal transduction, 
estrogens pass through a cell's phospholipid membrane and bind to their cognate 
receptors in the cytoplasm.  Following ligand binding, ERs are released from an 
inhibitory Hsp complex, homodimerize, and translocate to the nucleus to regulate 
downstream transcriptional programs.  Ligand-bound ERs typically interact directly with 
estrogen response elements (EREs) in the target gene's promoter region, however they 
have also been shown to associate with other transcription factor complexes with AP-1 
or SP-1 responsive elements (Kushner et al., 2000; Saville et al., 2000).  Mammalian 
species possess two estrogen receptors, ERα and ERβ, which are products of two 
genes found on distinct chromosomes (Enmark et al., 1997; Gosden et al., 1986).  Many 
fish species including zebrafish have three receptors, Esr1, Esr2a, and Esr2b; the Esr2 
subtypes resulted from genome duplication during teleost evolution (Postlethwait et al., 
1998).  Estradiol exhibits similar binding affinities to each ER isoform in fish and 
mammals (Menuet et al., 2002).  In all species, ERs show overlapping but distinct 
expression patterns in a number of organ systems, including the gonads, bone, muscle, 
liver, nervous system, vasculature, and adipose tissue (Chandrasekar et al., 2010; 
Matthews and Gustafsson, 2003).  Recently, an additional estrogen target has been 
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identified, G-protein coupled estrogen receptor 1 (GPER), that is believed to transduce 
the estrogen signal non-genomically via phosphorylation of downstream kinases (Liu et 
al., 2009).  Interestingly, whereas many NRs including the thyroid and RA receptors 
contain a ligand-binding cavity well tailored to their corresponding ligands, ERs possess 
a large ligand pocket relative to the size of estradiol (Brzozowski et al., 1997).  This 
feature allows ERs to bind compounds with a range of structures, permitting a number of 
environmental pollutants (xenoestrogens) and plant-derived compounds 
(phytoestrogens) to elicit transcriptional responses similar to physiological estrogens.   
 
Nuclear receptor signaling and the liver 
A number of studies have implicated roles for several NRs in liver development 
and homeostasis, however the extent of NR signaling's effects on hepatogenesis has not 
been fully elucidated.  Several components of the thyroid/retinoid NR signaling pathways 
are localized to the liver.  Vitamin A is stored in hepatic stellate cells (Zou et al., 1998), 
and the RA synthesizing enzyme Raldh4 is uniquely expressed in the mammalian liver 
(Lin et al., 2003).  The active form of vitamin D, 1α,25(OH)2D3, is synthesized in the liver, 
the liver expresses VDR, and ligand binding to VDR has been demonstrated in the livers 
of some fish species (Craig et al., 2008; Sundell et al., 1992).  Additionally, steroid NRs 
such as ERs are highly expressed in both the embryonic and adult liver (Chandrasekar 
et al., 2010; Matthews and Gustafsson, 2003).  The fact that many NR signaling 
components are found in the liver suggests they play an important role in the organ's 
development and regulation, however their effect on and interaction with other 
developmental signaling pathways during liver development has not been well 
characterized. 
To date, the most well described NR in liver development is hepatic nuclear 
factor 4α (Hnf4α), which until recently was considered an orphan NR but is now known 
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to bind linoleic acid (Yuan et al., 2009).  Hnf4α is expressed in hepatic progenitors as 
well as mature hepatocytes, and it binds roughly half of all genes expressed in the 
mouse liver (Odom et al., 2004).  Loss of Hnf4α results in aberrant hepatocyte 
morphology and loss of hepatic enzymes (Li et al., 2000; Parviz et al., 2003; Watt et al., 
2003).  Aside from Hnf4α, however, the role of individual NRs in liver development and 
homeostasis has not been fully illuminated, and this fact was the driver of the research 
presented in this dissertation. 
 
THESIS SUMMARY 
  In this dissertation, I examine the role of two NR signaling pathways in liver 
development.  In Chapter 2, I demonstrate that retinoic acid signaling is a positive 
regulator of hepatogenesis and identify distinct roles for RA-synthesizing enzymes and 
receptors during hepatic specification in zebrafish.  One RAR, Rargb, is uniquely 
responsible for conferring left-right positional information in the embryo.  Loss of rargb 
results in bilateral livers, midline hearts, and asplenia – defects associated with the 
human pathology right atrial isomerism, or Ivemark Syndrome.  I illustrate that Rargb 
functions upstream of Bmp to exert its effects on left-right patterning, uncovering a novel 
molecular mechanism by which organ asymmetry is regulated. 
 In Chapter 3, I describe the importance of estrogen signaling for proper hepatic 
differentiation.  In zebrafish, estrogen signaling negatively regulates embryonic liver 
development, and its effect is primarily mediated via the Esr2 receptor subtype.  
Exposure to estradiol prevents hepatocyte differentiation, and in mice, embryos exposed 
to excess estrogen similarly display an undifferentiated phenotype characterized by 
surfeit hepatoblasts.  In human embryonic stem cells, loss of activating epigenetic 
modifications at the ERβ locus, resulting in its downregulated expression, marks the 
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transition from definitive endoderm to differentiated liver cells.  These results indicate 
that estrogen acts across to species to regulate liver differentiation.   
 In my final chapter, I highlight ongoing and future work that will augment our 
understanding of the impact of RA and estrogen signaling on liver development and 
homeostasis.  I discuss a notable finding that estrogen acts in a biphasic manner during 
embryonic and larval liver development and describe ongoing studies intended to 
uncover the mechanism by which this occurs.  I also detail experiments that will be 
performed to elucidate the impact of NR signaling on adult liver homeostasis and 
disease.  Together, these completed and future investigations will expand our 
knowledge of NR signaling in liver development and promote the creation of novel and 
effective therapies for a number of diseases including developmental defects, hepatic 
dysfunction, and cancer. 
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ABSTRACT  
Developmental signals determine organ morphology and position during 
embryogenesis. To discover novel modifiers of liver development, we performed a 
chemical genetic screen in zebrafish and identified retinoic acid as a positive regulator of 
hepatogenesis.  Knockdown of the four RA receptors revealed that all receptors affect 
liver formation, however specific receptors exert differential effects.  Rargb knockdown 
results in bilateral livers but does not impact organ size, revealing a unique role for 
Rargb in conferring left-right positional information.  Bilateral populations of hepatoblasts 
are detectable in rargb morphants, indicating Rargb acts during hepatic specification to 
position the liver, and primitive endoderm is competent to form liver on both sides.  
Hearts remain at the midline and gut looping is perturbed in rargb morphants, suggesting 
Rargb affects lateral plate mesoderm migration.  Overexpression of Bmp during 
somitogenesis similarly results in bilateral livers and midline hearts, and inhibition of 
Bmp signaling rescues the rargb morphant phenotype, indicating Rargb functions 
upstream of Bmp to regulate organ sidedness.  Loss of rargb causes biliary and organ 
laterality defects as well as asplenia, paralleling symptoms of the human condition right 
atrial isomerism.  Our findings uncover a novel role for RA in regulating organ laterality 
and provide an animal model of one form of human heterotaxia.  
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INTRODUCTION 
During embryogenesis, the liver develops asymmetrically across the left-right 
axis.  In human heterotaxic syndromes, misalignment of the visceral organs is often 
associated with cardiac defects and impaired bile duct formation and typically requires 
surgical intervention.   Liver development originates in the endoderm where hepatic 
progenitors are specified from a multipotent precursor population.  Expression of liver-
specific transcription factors in a select population of endodermal cells is in part 
regulated by surrounding mesodermal tissues which provide inductive cues required for 
proper liver development and positioning.  Many of these signaling pathways have been 
independently characterized, however the sequence and integration of genetic networks 
regulating liver development have not been well established. 
In zebrafish, hepatoblasts are specified in the endodermal rod by 24 hours post-
fertilization (hpf), and between 24-28 hpf, the gut begins to loop to the left, concordant 
with asymmetrical movements of the lateral plate mesoderm (LPM) (Field et al., 2003; 
Horne-Badovinac et al., 2003; Ober et al., 2003).  Although the importance of 
mesoderm-endoderm signaling during liver development has been highlighted previously 
(Chung et al., 2008; Ober et al., 2006; Reiter et al., 1999; Reiter et al., 2001; Shin et al., 
2007), it is not clear how many of these developmental signals intersect during hepatic 
specification and positioning.   
Evidence that retinoic acid (RA) signaling is involved in endoderm formation first 
surfaced in a study of pancreatic specification in zebrafish (Stafford and Prince, 2002).  
Global inhibition of zebrafish RARs resulted in reduced or absent expression of 
endocrine and exocrine pancreas markers as well as hhex, a hepatic transcription factor.  
Analysis of zebrafish raldh2 mutants (neckless, aldh1a2um22, aldh1a2i26) also revealed 
similar disruptions in endoderm development (Alexa et al., 2009; Stafford and Prince, 
2002).  Despite these studies, the function of a number of integral RA pathway 
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members, including raldh3 and raldh4, and the impact of individual RARs on liver 
development remain unknown.   
RA signaling has been further suggested to affect organ laterality.  Early studies 
have demonstrated that inhibition of RA signaling or addition of excess RA leads to 
randomized heart looping in mice (Chazaud et al., 1999), and vitamin A deficient avian 
embryos develop reversed heart situs (Dersch and Zile, 1993), thereby suggesting a role 
for RA signaling in patterning organs across the left-right axis.  The mechanism by which 
RA regulates organ positioning has not been elucidated.  Lateral plate mesoderm (LPM) 
movements impact visceral organ positioning (Horne-Badovinac et al., 2001; Huang et 
al., 2008; Yin et al.), evoking the possibility that RA signaling exerts its effect on organ 
laterality via regulation of LPM migration.  
In this study, we define the role of RA signaling during liver specification and 
positioning.  In a large-scale chemical genetic screen, we identified RA as a regulator of 
normal liver development.  We demonstrate that both RA synthesis and receptor-
mediated signaling impact stages of hepatic specification, differentiation, and 
proliferation.  We show for the first time that raldh4 impacts liver development following 
hepatic specification.  Raraa, rarab, and rarga knockdowns lead to smaller livers, 
whereas rargb knockdown results in bilateral livers, demonstrating receptor-specific 
effects on liver development.  The heart and gut remain at the midline in rargb 
morphants, indicative of a left-right patterning defect, however Nodal signaling is 
unaffected in these embryos.  We observe that transient upregulation of Bmp signaling 
also results in midline hearts and bilateral livers.  Inhibition of Bmp signaling rescues the 
bilateral liver defect in rargb morphants, suggesting that RA normally inhibits Bmp 
signaling during organ laterality determination, and we indeed find that rargb knockdown 
results in elevated levels of phosphorylated Smads 1/5/8 in the developing embryo.  
Rargb morphants also develop bile duct defects and asplenia, and this phenotype 
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parallels the human heterotaxic syndrome right atrial isomerism, or Ivemark Syndrome 
(Ivemark, 1955) in which patients display a midline heart, midline or duplicated livers, 
biliary atresia, and asplenia, suggesting that proper RA signaling may be required for 
situs solitus of human organs. 
 
RESULTS 
A chemical genetic screen identifies retinoic acid signaling as a regulator of liver 
development  
To identify novel regulators of liver development, we conducted a chemical 
genetic screen in zebrafish (Figure 2-1).  We exposed wild type or lfabp:GFP fluorescent 
reporter embryos to a library of known bioactive compounds over the course of liver 
development (18-72 hpf) and scored embryonic liver size at 72 hpf by in situ 
hybridization or fluorescence microscopy, respectively.  Compounds having an effect on 
liver development were grouped by mechanism of action.  Out of 2640 compounds 
tested, 135 (5.1%) increased liver size, whereas 229 (8.7%) decreased liver size.  We 
identified a number of molecular pathways that impact liver growth, including retinoic 
acid (RA) signaling.  In particular, our screen uncovered eight hits corresponding to six 
compounds that affect RA signaling: vitamin A, all-trans retinoic acid (ATRA), 
isotretinoin, beta carotene, and the RA synthesis inhibitors diethylaminobenzaldehyde 
(DEAB) and disulfiram.   
 To corroborate our chemical screen findings and to determine the stage at which 
RA impacts liver development, we treated embryos with RA pathway compounds during 
specific time windows targeting hepatoblast specification (18-24 hpf), hepatoblast 
differentiation (24-48 hpf), and hepatocyte proliferation (48-72 hpf). At all time points, 
embryos treated with ATRA develop bigger livers, whereas embryos treated with DEAB  
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Figure 2-1.  A chemical genetic screen identifies retinoic acid as a regulator of 
embryonic zebrafish liver development. 
(A) Chemical genetic screen workflow.  Wild type (WT) or lfabp:GFP transgenic reporter 
fish were exposed to individual compounds from a library of 2640 known bioactives over 
the course of embryonic liver development (18-72 hpf).  Alterations in liver size were 
detected by fluorescence microscopy and in situ hybridization for lfabp.   
(B) Eight hits corresponding to six compounds were identified in the screen.  Retinoic 
acid, isotretinoin, retinol, and beta-carotene increased liver size, whereas RA pathway 
inhibitors diethylaminobenzaldehyde (DEAB) and disulfiram decreased liver size. 
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or AGN193109, a pan-RAR inhibitor, develop smaller livers as determined by lfabp in 
situ hybridization (Figure 2-2, A-F; Figure 2-3, A-B) and GFP expression in live  
lfabp:GFP reporter embryos (Figure 2-2, G-I) at 72 hpf.  These results suggest that RA 
signaling is important throughout all stages of hepatic specification, differentiation, and 
proliferation.  RA pathway inhibitors DEAB and AGN193109 were most penetrant during 
the earliest treatment window (18-24 hpf), with ~50% of embryos developing smaller 
livers (DEAB: n=136; AGN193109: n=25).  To confirm that our drug treatments impact 
RA signaling in the embryo, we treated cyp26a1:eYFP reporter fish with ATRA or DEAB 
at 18 hpf.  Cyp26a1 promotes degradation of RA and is induced by RA in an auto-
regulatory feedback loop (White et al., 1996; Abu-Abed et al., 2001; Sakai et al., 2001; 
Emoto et al., 2005).  Treatment of cyp26a1:eYFP embryos with ATRA led to increased 
fluorescence throughout the embryo, with particularly increased intensity in the brain and 
liver, whereas DEAB treatment decreased fluorescence in these regions (Figure 2-2, J-
L).  These results demonstrate that RA signaling is active in the embryonic liver and is 
modulated by chemical exposure. 
  To determine whether changes in liver size in chemically treated embryos are 
related to changes in hepatic cell proliferation, we assessed BrdU incorporation at 24 
hpf.  We found that proliferation levels correspond to liver size: ATRA-treated embryos 
have more BrdU+ cells, and DEAB and AGN193109-treated embryos contain fewer 
BrdU+ cells (Figure 2-2, M-O).  Quantification of BrdU+ cells in the area of the liver 
primordium (Figure 2-2O box, magnified in M’-O’) revealed a significant decrease in 
proliferating hepatic cells in DEAB (n=5, t-test, p=0.001) (Figure 2-2P) and AGN193109-
treated embryos (n=5, t-test, p=0.006) (Figure 2-3C) and an increase in BrdU+ cells in 
ATRA-treated embryos compared to DMSO controls.  We verified these changes in 
hepatic cell proliferation by performing FACS at 72 hpf on lfabp:GFP embryos exposed 
to RA pathway compounds from 18-24 hpf.  Quantification of GFP+ cells uncovered  
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Figure 2-2 (next page). Retinoic acid signaling enhances embryonic liver 
development.   
(A-F) In situ hybridization for lfabp at 72 hpf reveals differences in liver size after 
chemical exposure at 18 hpf.  ATRA treatment leads to greater lfabp expression, 
whereas DEAB treatment leads to reduced lfabp expression.  First row, lateral view.  
Second row, dorsal view. 
(G-I) Fluorescence microscopy of lfabp:GFP reporter fish at 72 hpf confirms in situ 
hybridization results in (A-F). 
(J-L) Fluorescence microscopy of cyp26a1:eYFP reporter fish at 72 hpf demonstrates 
changes in RA signaling activity in chemically treated embryos.  Arrowheads highlight 
the liver. 
(M-O) BrdU whole mount immunostaining of 24 hpf embryos demonstrates that ATRA-
treated embryos show higher levels of proliferation in the liver primordium (black 
rectangle) compared to DEAB and DMSO-treated controls.   
(M’-O’) Enlarged images of (M-O) illustrating individual proliferating cells in the liver 
primordium. 
(P) Quantification of the number of BrdU+ cells/field (black rectangle in O). 
(Q) FACS quantification of percent GFP+ cells in chemically treated lfabp:GFP embryos 
reveals that ATRA-treated embryos contain more hepatocytes and DEAB-treated 
embryos contain fewer hepatocytes than DMSO-treated controls. 
(R) qPCR analysis reveals differences in the relative expression of the hepatocyte 
marker transferrin in ATRA and DEAB-treated embryos at 72 hpf compared to DMSO-
treated controls (where control expression levels were normalized to 1.0). 
Scale bars: 100 microns. 
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Figure 2-2 (continued)
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Figure 2-3. The pan-RAR antagonist AGN193109 reduces liver size and hepatic 
proliferation.   
(A-B) Embryos treated with the RAR antagonist AGN193109 from 18-24 hpf develop 
smaller livers compared to DMSO-treated controls as shown by lfabp expression at 72 
hpf.  Lateral views. 
(C) Quantification of the number of proliferating BrdU+ cells in the area of the liver 
primordium (see Figure 1, black rectangle) in AGN193109-treated embryos at 24 hpf. 
(D) FACS quantification of percent GFP+ cells in chemically treated lfabp:GFP embryos 
reveals that AGN193109-treated embryos contain fewer hepatocytes than DMSO-
treated controls. 
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significant changes in hepatocyte number in compound-treated embryos compared to 
controls (DMSO versus ATRA p=2.0x10-5, DEAB p=8.6x10-5, AGN193109 p=0.0002; 
ATRA versus DEAB p=4.6x10-8, AGN p=1.1x10-6; DEAB versus AGN p=0.69) (Figure 2-
2Q, Figure 2-3D).  TUNEL analysis confirmed that changes in liver size are not related to 
hepatic cell death (data not shown).  qPCR analysis of embryos exposed to RA pathway 
compounds further demonstrated that liver size and hepatocyte number correlate with 
expression levels of the hepatocyte marker transferrin at 72 hpf, indicating that the 
observed changes are not specific to lfabp (Figure 2-2R) (DMSO versus ATRA: p=0.02; 
versus DEAB: 0.07; ATRA versus DEAB p=0.01).  Together, these results demonstrate 
that RA signaling enhances embryonic liver growth. 
Retinaldehyde dehydrogenase (Raldh) enzymes are responsible for converting 
retinaldehyde to RA.  The zebrafish expresses three Raldhs – raldh2, raldh3, and raldh4 
(Begemann et al., 2001; Liang et al., 2008; Pittlik et al., 2008).   Raldh2 is expressed in 
the lateral plate mesoderm during somitogenesis, and zebrafish and medaka raldh2 
mutants display defective liver development (Begemann et al., 2001; Alexa et al., 2009; 
Negishi et al., 2010).  Raldh3 is expressed in the eye and is therefore unlikely to have a 
role in liver development.  Raldh4 is expressed in the developing liver at 48 hpf (Liang et 
al., 2008), however targeted knockdown of raldh4 has not been reported. To determine 
whether Raldh4 is required for normal liver development and whether its temporal 
requirement is distinct from that of Raldh2, we knocked down raldh2 and raldh4 using 
ATG start site morpholinos (MOs).  Liver size was subsequently assessed by in situ for 
prox1 at 30 and 48 hpf and lfabp at 72 hpf.  At 30 hpf, 100% of raldh2 knockdown 
embryos and 4% of raldh4 knockdown embryos developed small livers compared to 6% 
in controls (n≥25/condition) (Figure 2-4, A-C).  Similarly, at 48 hpf, 7% of control 
embryos, 100% of raldh2 morphants, and 17% of raldh4 morphants developed small 
livers (n≥18/condition) (Figure 2-4, D-F).  When examined at 72 hpf, 0% of control  
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Figure 2-4. Raldhs 2 and 4 temporally regulate liver development. 
(A-I) Wild type embryos were injected with raldh2 or raldh4 MO at the 1-cell stage, and 
liver development was assessed over the next 72 hours.  In situ hybridization for the 
hepatoblast marker prox1 at 30 hpf (A-C) and 48 hpf (D-F) and hepatocyte marker lfabp 
at 72 hpf (G-I) demonstrates distinct temporal requirements for Raldh2 and Raldh4 
during liver development.  Arrowheads denote the liver primordium, and the dotted lines 
outline the liver.  Scale bars: 100 microns. 
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embryos, 80% of raldh2 morphants, and 82% of raldh4 morphants developed small 
livers (n≥40/condition) (Figure 2-4, G-I).  Our results indicate that raldh2 is required 
throughout hepatogenesis, whereas raldh4 is primarily required following hepatocyte 
specification (after 48 hpf).  Additionally, in a separate experiment in which we titered 
individual MO doses to prevent toxicity from double MO injection, we found that 0% of 
uninjected embryos, 31% of raldh2 morphants, 21% of raldh4 morphants, and 76% of 
raldh2+4 double morphants developed small livers at 72 hpf (n≥14/condition).  These 
data suggest that Raldh2 and 4 enzymes act sequentially and synergistically during 
hepatogenesis and corroborate our timed chemical exposure studies.   
 
Retinoic acid signaling impacts liver size and laterality by receptor-specific 
mechanisms 
 The zebrafish expresses two RA receptor (RAR) α subtypes, raraa and rarab, and 
two RAR γ subtypes, rarga and rargb (Hale et al., 2006).  No RAR β has been identified 
to date.  Combinatorial RAR knockdowns result in defects in hindbrain, limb, and 
pharyngeal arch development (Linville et al., 2009), but receptor-specific roles in liver 
development have not been described.  To elucidate individual receptor contributions to 
hepatogenesis, we knocked down each receptor using previously published MOs 
(Linville et al., 2009).  Knockdown of RARs aa, ab, and ga, primarily resulted in smaller 
livers (raraa: 43% smaller livers, n=28; rarab: 15%, n=34; rarga: 47%, n=38) (Figure 2-5, 
A-D, G-J), suggesting that these receptors act redundantly during hepatic specification 
and/or hepatocyte proliferation.  Interestingly, we found that knockdown of rargb caused 
embryos to develop bilateral livers (29%, n=105) (Figure 2-5, E and K), suggesting that 
this receptor regulates liver laterality. Combinatorial knockdown of all four RARs resulted 
in even smaller (82%), sometimes absent livers (18%, n=22), indicating that RARs are 
required for normal hepatic specification (Figure 2-5, F and L).  These results are  
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Figure 2-5 (next page). Retinoic acid receptors differentially impact liver 
development and laterality.   
(A-L) Lfabp expression at 72 hpf in RAR morphant embryos.  Loss of RARs raraa, rarab, 
and rarga leads to a reduction in liver size (A-D, G-J), whereas loss of rargb causes 
embryos to develop bilateral livers (E, K, K’).  Embryos simultaneously injected with a 
lower dose of all four RAR MOs develop small livers or none at all (F, L).  
(M-P) Embryos treated with the RARγ antagonist MM11253 over the time points given 
develop bilateral livers, confirming genetic knockdown data. 
(Q) FACS quantification of percent GFP+ cells in lfabp:GFP RAR morphant embryos 
reveals that rargb morphant embryos with bilateral livers contain significantly more GFP+ 
hepatocytes than control siblings.  Embryos injected with raraa, rarab, rarga, and rargb 
in combination have roughly half as many GFP+ hepatocytes as control embryos. 
Scale bars: 100 microns. 
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Figure 2-5 (continued) 
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corroborated by the fact that single RAR knockout mice are viable, whereas double 
knockouts display a number of developmental defects (Mark et al., 2006). 
 To confirm our rargb knockdown results chemically, we treated embryos with a 
selective RARγ antagonist, MM11253, over the course of hepatogenesis (18-72 hpf).  
Whereas DMSO controls developed left-sided livers, 24% (n=33) of MM11253-treated 
embryos developed bilateral livers (Figure 2-5, M-N), confirming our MO knockdown 
results.  Additionally, bilateral livers developed in embryos treated during shorter, early 
time windows (18-24 and 24-48 hpf) (Figure 2-5, O-P), suggesting that Rargb exerts its 
effect during hepatic specification.  FACS quantification of RAR MO-injected lfabp:GFP 
reporter fish at 72 hpf demonstrated that rargb morphants with two livers have 
significantly more hepatocytes than their control siblings, whereas raraa knockdown 
embryos have fewer GFP+ hepatocytes than control siblings, and combinatorial 
knockdown embryos fewer still (Figure 2-5Q) (rargb MO versus control, p=0.00017; 
versus raraa MO, p=0.00023; versus combo MO, p=2.40 x 10-6).  These data illustrate 
that individual RARs have specific effects on liver specification and laterality.  
 To further elucidate the timing of rargb’s effect on liver laterality, we injected 
rargb MO and assessed hepatic bud formation at 30 hpf using the hepatoblast marker 
prox1 and at 48 hpf using the pan-endodermal marker foxA3.  Whereas control embryos 
displayed left-sided liver buds at 30 hpf, 26% of rargb morphants (n=23) developed 
bilateral populations of hepatoblasts (Figure 2-6, A-B).  This percentage corresponds to 
the number of bilateral livers seen at 72 hpf (29%).  We also observed that some rargb 
morphants display midline liver buds at 30 hpf (21%, n=23).  We did not observe midline 
livers at 72 hpf in rargb morphants, suggesting that midline populations of hepatoblasts 
ultimately resolve into unilateral hepatocyte populations or split into two liver buds.  
These results corroborate our early (18-24, 24-48 hpf) MM11253 treatments, 
demonstrating that rargb knockdown impacts liver laterality during hepatic specification.  
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Figure 2-6. Rargb knockdown impacts the left-right asymmetry of visceral organs.   
(A-B) Prox1 expression demonstrates that hepatic progenitors normally migrate to the 
left of the midline at 30 hpf (A, black arrowhead).  Loss of rargb results in bilateral (B) or 
midline (B’) hepatoblast populations. 
(C-D) In situ hybridization for the pan-endodermal marker foxA3 at 48 hpf demonstrates 
that loss of rargb results in bilateral livers (black arrowheads) that are sometimes 
accompanied by bilateral pancreata (white arrowheads). 
(E-F) Rargb morphants develop gut looping abnormalities (arrow), as demonstrated by 
shh expression at 48 hpf. 
(G, H) Hand2 expression at 48 hpf demonstrates aberrant LPM migration in rargb 
morphants (H).  Insets in (G, H) highlight the differences in LPM phenotypes. 
Scale bars: 100 microns. 
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Examination of foxA3 expression at 48 hpf further confirmed that rargb knockdown leads 
to bilateral livers (Figure 2-6, C-D).  In control embryos, the pan-endodermal marker 
foxA3 marks the left-sided liver and right-sided pancreas.  In rargb morphants, we 
identified bilateral livers in 30% of MO-injected embryos (n=28).  We also discovered 
that in some cases, embryos with bilateral livers also developed bilateral pancreata (7%, 
n=28).  Whereas most bilateral livers occurred in the presence of a normal right-sided 
pancreas, bilateral pancreata always occurred in conjunction with bilateral livers (Figure 
2-6D).  These results demonstrate that rargb knockdown impacts the laterality of the 
liver and other endoderm derivatives.   
 
Rargb knockdown affects organ laterality  
 In zebrafish, cardiac progenitors develop bilaterally, coalesce at the midline, then 
the nascent heart tube jogs asymmetrically to the left of the midline around 1 dpf 
(Bakkers et al., 2009).  In mice, the cardiac mesoderm and septum transversum 
mesenchyme provide Fgf and Bmp signals to specify hepatic progenitors in the overlying 
endoderm (Jung et al., 1999; Rossi et al., 2001), and loss of these signals in zebrafish 
prevents hepatic specification (Shin et al., 2007).  It is therefore possible that defective 
heart positioning and ectopic inductive cues precede the development of bilateral livers.  
We have observed the coincidence of heart and liver laterality defects in other contexts; 
double in situ hybridization for hepatoblast and cardiac markers prox1 and cmlc2, 
respectively, revealed that cardia bifida mutants miles apart (mil) (Kupperman et al., 
2000) also develop bilateral livers (Figure 2-7).  Accordingly, to determine whether 
laterality defects in the endoderm are accompanied by heart jogging defects, we 
examined expression of the pan-cardiomyocyte marker cmlc2 at 26 hpf.  Control 
embryos developed left-sided heart tubes, whereas 33% of rargb morphants displayed 
midline heart tubes (n=33) (Figure 2-8, A and D).  Knockdowns of RARs raraa, rarab,  
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Figure 2-7.  Cardia bifida mutants miles apart (mil) develop bilateral livers. 
(A-B) In situ hybridization at 30 hpf for heart and hepatoblast markers cmlc2 and prox1, 
respectively, demonstrates that cardia bifidia mutants mil develop two hearts (white 
arrowheads) and bilateral livers (black arrowheads). 
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Figure 2-8 (next page). Midline hearts and bilateral livers correlate in rargb 
morphants. 
(A-F) Control embryos develop leftward jogging hearts as shown by the pan-
cardiomyocyte marker cmlc2 at 26 hpf (A) and chamber-specific markers vmhc and 
amhc at 30 hpf (B, C), whereas rargb morphants develop midline ventricles (D, E).   
(G, H) Embryos treated with the RARγ antagonist MM11253 develop midline hearts, 
confirming genetic knockdown data. 
(I) RARγ function is evolutionarily conserved.  The midline heart phenotype of rargb 
morphant embryos is rescued by injection of mouse Rarg mRNA.  
(J) Midline hearts and bilateral livers correlate in the same embryo.  Cmlc2:GFP reporter 
fish injected with rargb MO were sorted by heart phenotype at 30 hpf, then liver laterality 
was assessed at 72 hpf by lfabp expression.  
Scale bars: 100 microns. 
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Figure 2-8 (continued)
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and rarga did not affect heart jogging (data not shown).  Examination of chamber 
specific markers atrial and ventricular myosin heavy chain (amhc and vmhc,  
respectively) revealed that the ventricle is specifically affected by rargb knockdown 
(36%, n=28) (Figure 2-8, B-C and E-F).  We also confirmed our genetic results 
chemically by treating embryos with the selective RARγ antagonist MM11253 over the 
course of cardiac jogging (14-26 hpf) and examining cmlc2 expression at 26 hpf.  
MM11253-exposed embryos also displayed heart jogging defects (25%, n=24) (Figure 2-
8, G-H), further indicating that loss of rargb perturbs heart laterality.   
   Just as zebrafish rargb morphants develop midline ventricles, dominant 
negative RARγE305 chimeric mice exhibit misaligned or unlooped ventricles (Iulianella 
and Lohnes, 2002), suggesting that RARγ functions similarly during vertebrate 
organogenesis.  To demonstrate evolutionary conservation of RARγ function during 
cardiac development, we performed a rescue experiment in which zebrafish rargb MO 
was co-injected with mouse Rarg mRNA at the 1-cell stage, and vmhc expression was 
evaluated at 30 hpf.  Compared to controls (0% midline ventricles, n=20), 35% (n=34) of 
rargb morphants developed a midline ventricle (control versus MO p=0.0019), whereas 
only 9% (n=22) of MO+mRNA co-injected embryos displayed this defect (MO versus 
MO+mRNA p=0.0315) (Figure 2-8I).  We also examined lfabp expression at 72 hpf to 
determine whether mouse Rargb mRNA rescues the rargb morphant liver phenotype.  
All controls developed left-sided livers (n=23), whereas 22% (n=41) of rargb morphants 
(control versus MO p=0.0208) and 10% (n=30) of MO+mRNA co-injected embryos had 
bilateral livers (MO versus MO+mRNA p=0.218).  Although we consistently see a 
reduction in the number of bilateral livers in co-injected embryos, we suspect that the 
rescue is less effective at a later stage due to persistent toxicity from the presence of two 
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exogenous nucleotide constructs.  Together, our results demonstrate that RARγ function 
is conserved between fish and mammals. 
To demonstrate that heart and endoderm defects are linked in the same embryo, 
we injected rargb MO into cmlc2:GFP reporter fish, sorted embryos by heart phenotype 
(left or midline) at 30 hpf by fluorescence microscopy, and assessed lfabp expression by 
in situ at 72 hpf.  If heart and liver defects correlate in the same embryo, this would 
suggest a unifying underlying cause (e.g., gut looping defect) or that one defect 
precedes the other (e.g., altered cardiac asymmetry governs liver positioning).  We 
found that heart and liver defects are significantly correlated in the same embryo 
(p<0.0001, Chi-squared analysis).  Specifically, whereas only 10% of embryos with a 
left-sided heart developed bilateral livers (n=71), 74% of embryos with a midline heart 
developed bilateral livers (n= 31) (Figure 2-8J).  Together, our results demonstrate that 
rargb knockdown impacts heart (ventricle) as well as endoderm laterality and suggest 
that these phenotypes are linked.   
Because rargb morphants develop endoderm and cardiac defects, we reasoned 
that this might be due to an underlying cause such as aberrant LPM migration.  Failed 
gut looping is often associated with bilateral endodermal organs (Chen et al., 2001), and 
zebrafish mutant for the bHLH transcription factor hand2 exhibit failed LPM migration 
and develop gut looping defects and bilateral livers and pancreata (Yin et al., 2010).  To 
assess this possibility, we examined whether gut looping is affected in rargb morphants 
by observing expression of sonic hedgehog (shh) and hand2 at 48 hpf.  We found that 
the gut, which normally loops leftward in control embryos, did not loop or remained at the 
midline in rargb morphant embryos (shh: 29% midline, 54% weak looping, n=24; hand2: 
73%, n=22) (Figure 2-6, E-H).  We tested additional markers for the thyroid, 
hypothalamus, and kidney (nkx2.1a, slc20a1a, slc12a3) and did not note any defects 
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(data not shown), indicating that rargb knockdown impacts only a subset of 
mesendodermal organs. 
 
Nodal signaling is unaffected in rargb morphants 
 Nodal signaling is a master regulator of left-right asymmetry (Shen, 2007).  Nodal 
signals originating in the node propagate anteriorly in the left LPM and impact endoderm 
and heart asymmetry.  To determine whether laterality defects seen in rargb morphants 
are due to altered Nodal signaling, we examined the expression of the zebrafish Nodal 
signal southpaw (spaw), downstream effector pitx2, and Nodal antagonists lefty1 and 
lefty2 during somitogenesis (18-22 somites).  Both control and rargb morphant embryos 
displayed normal left-sided expression of spaw, pitx2, and lefty2, and the molecular 
midline barrier lefty1 remained intact (Figure 2-9), demonstrating that Rargb’s impact on 
organ laterality is Nodal-independent.  We also treated embryos with the RARγ 
antagonist MM11253 in two time windows targeting early development, 32 cell-2 somite 
and 2 somite-20 hpf, and found that Nodal signals remain left-sided in 91% (n=66) and 
92% (n=51) of these embryos, respectively.  The results of these chemical exposures 
further demonstrate that inhibition of rargb during early development does not impact 
Nodal signaling.  It was recently shown that LPM migration defects in hand2 mutants are 
not due to Nodal defects alone; in spaw morphants, the direction of LPM migration is 
randomized, whereas in hand2 mutants, LPM migration does not occur at all (Yin et al., 
2010).  Furthermore, although previous studies have suggested that early inhibition of 
RA signaling (prior to the 2 somite stage) affects Nodal signaling, these embryos 
ultimately develop situs inversus rather than duplicated or midline organs (Huang et al., 
2011), bolstering our observations that rargb morphant defects are likely due to defects 
in LPM migration rather than misexpression of global laterality signals.   
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Figure 2-9. Loss of rargb does not affect Nodal signaling. 
Rargb knockdown does not affect normal left-sided expression of Nodal signals spaw (A, 
B), pitx2 (C, D), or lefty2 (G, H) (arrows) or the molecular midline barrier lefty1 (E, F). 
White dotted lines denote the midline. 
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Rargb affects Bmp signaling via altered phospho-Smad levels during organ 
laterality determination 
Bmp4 is expressed asymmetrically in the left LPM between 20-22 somites, and 
this expression pattern leads to greater activation of phosphorylated Smads on the left 
side and is correlated with leftward cardiac jogging (Chen et al., 1997; Chocron et al., 
2007; Smith et al., 2008).  Because Bmp signaling is important for determining heart 
laterality, we investigated whether ectopic Bmp signaling perturbs liver laterality.  We 
heat shocked inducible hs:bmp2b zebrafish embryos at 12 somites, prior to cardiac 
jogging and hepatic specification, and examined heart and liver development by in situ 
for cmlc2 (30 hpf) and lfabp (72 hpf), respectively.  At 30 hpf, 5% (n=100) of non heat 
shocked (hs-) control sibling embryos and 72% (n=79) of heat shocked embryos (hs+) 
displayed midline hearts (Figure 2-10A).  Similarly, at 72 hpf, 4% (n=106) of hs- embryos 
compared to 33% (n=111) of hs+ embryos developed bilateral livers (Figure 2-10B).  
These data demonstrate that rargb knockdown and bmp2b overexpression result in the 
same phenotype, suggesting interplay between RA and Bmp signaling during laterality 
determination. 
 Given that loss of rargb or gain of bmp2b expression results in bilateral livers and 
midline hearts, we hypothesized that RA signaling antagonizes Bmp signaling during 
organ development (or vice versa).  To determine whether RA inhibits Bmp signaling, we 
injected rargb MO at the 1-cell stage then treated these embryos with the Bmp inhibitor 
dorsomorphin from 14-17 hpf.   At 72 hpf, we assessed whether Bmp inhibition rescued 
rargb morphants’ bilateral liver phenotype.  Whereas 3% of uninjected/DMSO-treated 
control embryos (n=101) and 1% of uninjected/dorsomoprhin-treated embryos (n=137) 
developed bilateral livers, 24% of rargb MO-injected/DMSO-treated embryos developed 
bilateral livers (n=144; p-value<0.0001 for MO/DMSO versus uninjected/DMSO).  In 
contrast, 17% of rargb MO/dorsomorphin-treated embryos (n=163) developed bilateral  
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Figure 2-10 (next page). Rargb negatively regulates Bmp activity and localization 
in vivo. 
(A-B) Overexpression of Bmp in heat shock inducible hs:bmp2b embryos results in 
midline hearts (A) and bilateral livers (B), paralleling the phenotype of rargb morphants. 
(C) Treatment of rargb morphant embryos with the Bmp inhibitor dorsomorphin results in 
a reduction in the number of bilateral livers compared to DMSO-treated control rargb 
morphants. 
(D) Western blot for Bmp effectors phospho-Smads 1/5/8 in uninjected control (Un) and 
rargb MO-injected embryos (MO) at 18 hpf.  Band density values normalized to Actin 
demonstrate that loss of rargb results in increased expression of p-Smads 1/5/8.  
Embryos treated with the Bmp inhibitor dorsomorphin (DM) show reduced p-Smad 1/5/8 
expression compared to DMSO-treated controls. 
(E-H) Fluorescence microscopy of Bmp response element reporter fish BRE:eGFP.  At 
20 hpf, control embryos display greater Bmp activity on the left side (E), whereas rargb 
morphants display symmetrical Bmp activity (F).  Altered Bmp localization at 20 hpf 
corresponds to heart laterality defects at 36 hpf in rargb morphants (H).  White dotted 
lines denote the midline (E, F) or outline the heart tube (G, H). 
Scale bars: 100 microns. 
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Figure 2-10 (continued)
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livers (Figure 2-10C; p-value = 0.1565 for MO/DMSO versus MO/dorsomorphin).  These 
results represent six independent experiments in which the same rescue trend was 
noted in each.  Together, these results demonstrate that inhibition of Bmp signaling 
rescues the rargb morphant phenotype and suggesting that Bmp acts downstream of 
Rargb during laterality determination.  
We also performed the reverse experiment by first overexpressing Bmp then 
treating embryos with a RARγ agonist, CD1530.  Hs:bmp2b transgenic embryos were 
heat-shocked at 12 somites then treated with CD1530 from 16-18 somites, and liver 
development was assessed at 72 hpf by lfabp expression.  Whereas hs-/CD1530- and 
hs-/CD1530+ embryos did not display laterality defects, 25% of both hs+/CD1530- and 
hs+/CD1530+ embryos (n≥13/condition) developed bilateral livers (data not shown).  
These data further indicate that Rargb acts upstream of Bmp signaling to govern organ 
laterality. 
 Our in vivo data suggest that loss of rargb leads to an increase in Bmp signaling, 
since loss of rargb and overexpression of bmp2b result in the same laterality defects, 
and inhibition of Bmp signaling by dorsomorphin rescues the rargb morphant phenotype.  
To corroborate our in vivo findings, we examined expression levels of phosphorylated 
Smad1/5/8 (p-Smads), cytoplasmic effectors of Bmp signaling, in whole embryo lysates 
at 18 hpf.  We found that rargb knockdown led to a ~60% increase in p-Smad1/5/8 
expression levels compared to control embryos by Western blot analysis (Figure 2-10D).  
Whereas expression patterns of Bmp-related smads 1/5 as well as that of co-Smad 
smad4 are unchanged at the level of in situ hybridization (data not shown), total levels of 
Smad 1/5/8/9 proteins are also increased in rargb morphants as determined by Western 
blot analysis, indicative of decreased degradation (Figure 2-11).  Together, our results 
indicate that Rargb normally inhibits Bmp signaling by reducing levels of active 
cytoplasmic Bmp effectors p-Smad1/5/8. 
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Figure 2-11.  Levels of Smad 1/5/8/9 proteins are increased in rargb morphants.  
Western blot for Smad 1/5/8/9 on whole embryo lysates at 18 hpf.  Loss of rargb (MO) 
results in increased Smad protein levels compared to uninjected controls (Un).  Band 
density values normalized to Actin. 
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 In addition to examining p-Smad1/5/8 levels in embryo lysates, we also 
investigated whether changes in Bmp signaling were visible in the cardiac field of living 
embryos using transgenic Bmp response element reporter fish BRE:eGFP that are 
responsive to Smad1/5 activity (Laux et al., 2011).  In wild type embryos, Bmp signaling 
is active asymmetrically (Smith et al., 2008), with greater signaling occurring in the left 
LPM around the 20-22 somite stage, leading to a leftward jogging heart tube by 24 hpf.  
Compared to control embryos that displayed asymmetric Bmp activity (100%; 6 left, 1 
right), 53% of rargb morphant embryos (n=15) exhibited symmetrical Bmp activity at 22 
somites (Figure 2-10, E-F).  We examined these same embryos at 30 hpf to assess 
whether changes seen in Bmp signaling at 22 somites ultimately affected heart tube 
development.  Because Bmp remains active in the heart at this stage, the direction of 
cardiac jogging can be assessed in BRE:eGFP embryos.  Both control and rargb 
morphant embryos’ hearts jogged according to earlier sidedness of Bmp activity.  
Specifically, all control embryos developed asymmetrically jogged hearts (6 left, 1 right; 
100% asymmetrical), whereas 40% of rargb morphant embryos developed midline 
hearts (6 midline, 7 left, 2 right; 60% asymmetrical) (Figure 2-10, G-H; p-value = 0.0225 
for control versus rargb morphant embryos showing asymmetrical – left or right – versus 
symmetrical Bmp signaling).  Correspondingly, we also found that control embryos 
displayed normal asymmetric expression of bmp4 around the cardiac cone, whereas 
bmp4 expression is symmetrical in rargb morphants as determined by in situ 
hybridization at 21 somites (Figure 2-12, A-B).  Together, these results demonstrate in 
vivo that loss of rargb affects Bmp activity and ultimately organ laterality.   
 
The zebrafish rargb morphant phenotype resembles human right atrial isomerism 
Rargb morphant laterality defects are strikingly similar to the human heterotaxic 
syndrome left/right atrial isomerism in which patients display both a midline heart and a  
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Figure 2-12.  Bmp4 is symmetrically expressed in rargb morphants.  
(A, B) In situ hybridization for bmp4 expression in the cardiac cone of control and rargb 
morphant embryos at 21 somites.  Black dotted lines denote the midline.  
(C) Rargb expression at 18 somites in wild type embryos.   
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duplicated or midline liver (Sutherland and Ware, 2009; Zhu et al., 2006).  Biliary atresia, 
characterized by blocked or absent hepatic bile ducts, is another hallmark of the human 
heterotaxic condition (Sutherland and Ware, 2009) so we investigated whether rargb 
morphants also display biliary defects.  We first examined tp1bglob:eGFP reporter fish in 
which the Epstein-Barr Virus TP1 gene, placed upstream of the rabbit β-globin minimal 
promoter acts as a Notch-responsive element (Parsons et al. 2009).  Notch signaling is 
required for normal bile duct specification and development and highlights the biliary tree 
as early as 76 hpf (Lorent et al., 2010; Lorent et al., 2004).  Compared to control larvae 
that developed intrahepatic bile ducts with a normal latticework appearance, 56% (n=52) 
of rargb MO-injected larvae exhibited dysmorphic bile duct architecture characterized by 
reduced intrahepatic branching and connectivity (Figure 2-13, A-B).  In addition to 
examining bile duct development in vivo in Notch reporter fish, we also investigated the 
expression of the bile duct cell marker 2F11 (Crosnier et al., 2005) by whole mount 
immunostain in 5 dpf larvae.  Confocal projections of control embryos revealed a regular, 
highly branched network of intrahepatic bile ducts, whereas rargb morphant embryos 
displayed less extensive ductular networks and enlarged cell bodies at duct junctions 
(84%, n=19) (Figure 2-13, C-F), defects reminiscent of the human pathophysiology of 
biliary atresia.  The etiology of biliary atresia remains unknown, however our results 
suggest that loss of rargb negatively impacts bile duct formation.   
Patients with heterotaxia often exhibit asplenia or polyspenia (Ivemark, 1955; 
Sutherland and Ware, 2009), so we also investigated whether rargb morphants develop 
spleen defects by examining expression of hox11 at 5 dpf.  Thirty-four percent (n=58) of 
rargb morphants had a small or absent spleen, compared to only 3% of control embryos 
(n=33, p-value = 0.0005) (Figure 2-13, G-I), suggesting that loss of rargb results in a 
phenotype similar to human asplenia.  Patients with right atrial isomerism, or Ivemark  
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Figure 2-13 (next page). Rargb morphants develop biliary defects. 
(A-B) Fluorescence microscopy of Notch reporter fish tp1bglob:eGFP at 5 dpf.  Rargb 
morphant embryos develop defective bile duct architecture (B, arrows) compared to the 
normal latticework appearance of the control embryo’s biliary tree (A). 
(C-F) Confocal microscopy of 2F11 whole mount immunostained embryos at 5 dpf.  
Rargb morphant embryos display enlarged cell bodies (D-E, white arrowheads) and 
reduced branching of intrahepatic bile duct networks (F) compared to control embryos 
(C).  White dotted lines outline the liver.  Images are taken at the same magnification.   
(G-I) In situ hybridization for hox11 at 5 dpf.  Rargb morphants display small (H) or 
absent (I) spleens compared to control embryos (G).  Black arrowheads denote the 
spleen. 
Scale bars: 50 microns. 
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Figure 2-13 (continued) 
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Syndrome, typically display apslenia (Ivemark, 1955), whereas patients with left atrial 
isomerism predominantly develop polyspenia (Zhu et al., 2006).  Thus, the rargb 
morphant phenotype more closely resembles right atrial isomerism.  Together, the 
laterality, biliary, and spleen defects seen in rargb morphants implicate RARγ in human 
heterotaxic syndromes and suggest that RA signaling is important for situs solitus of 
human organs.   
 
DISCUSSION 
 In this study, we identified RA as a regulator of zebrafish hepatogenesis and 
elucidated roles for RA signaling in organ development and positioning.  We have shown 
that RA synthesis by Raldh enzymes and downstream signal transduction by RARs are 
both important for proper liver development.  RAR knockdowns reveal that individual 
receptors exert specific effects during organogensis.  Loss of Rargb results in duplicated 
livers, midline hearts, and unlooped guts, and epistasis analyses demonstrate that 
Rargb functions upstream of Bmp to affect organ positioning.  Rargb morphants also 
develop bile duct defects and asplenia, which in combination with their laterality 
phenotypes, parallel the human heterotaxic syndrome right atrial isomerism.  
 It has been suggested that RA signaling is involved in endoderm development 
(Stafford and Prince, 2002; Alexa et al., 2009; Negishi et al., 2010), however roles for 
specific RARs in liver development and positioning have not been described.  Our 
finding that one receptor, Rargb, impacts organ laterality can be explained by differences 
in zebrafish RAR expression patterns and divergent RAR phylogenies (Waxman and 
Yelon, 2007).  First, rargb is located on a different chromosome than rarga, suggesting 
that these may be different genes rather than splice variants.  Furthermore, whereas 
rarga is not expressed maternally, rargb is expressed both maternally and zygotically.  
Phylogenetic analyses have also established that rargb is more closely related to mouse 
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and human RARG, supporting our results demonstrating evolutionary conservation of 
RARγ function.  Knockdown of the RA transport protein Rbp4 results in the formation of 
two liver buds (Li et al., 2007), corroborating a role for RA signaling in liver progenitor 
positioning.   
 Although Nodal is known to be a master regulator of left-right asymmetry (Shen 
2007), we did not find its expression affected by loss of rargb.  It has previously been 
shown that blocking RA signaling before the 2 somite stage alters Nodal signaling in 
zebrafish (Huang et al. 2011), but organs are primarily reversed rather than duplicated or 
midline in these embryos.  Furthermore, studies in other species have suggested that 
RA signaling can impact organ laterality without disrupting early left-right signals.  In 
Xenopus, laterality defects manifest in embryos treated with DEAB after Nodal has 
established the left-right axis (Lipscomb et al., 2006), and Raldh2 null mice develop 
unlooped hearts despite Nodal being unaffected (Niederreither et al., 2001).  
Characterization of the zebrafish mutant heart and soul (has), which displays failed gut 
looping and symmetrical visceral organs (Horne-Badovinac et al. 2001), revealed that 
these laterality defects are accompanied by normal spaw and pitx2 expression (Horne-
Badovinac et al., 2003), further suggesting that left-right patterning defects can manifest 
in the presence of normal Nodal signaling. 
 RA and Bmp signals intersect in other developmental contexts (Sheng et al. 
2010; Shimono et al. 2011; Song et al., 2007; Tehrani and Lin, 2010), so we 
hypothesized that RA may exert its effect on organ development by regulating Bmp 
activity.  In mice, Bmps generated adjacent to the cardiac mesoderm in the septum 
transversum mesenchyme induce hepatic progenitors in the nearby endoderm and 
promote outgrowth of the liver primordium (Jung et al., 1999; Rossi et al., 2001).  
Studies in mice and chick have demonstrated that RARG inhibits Bmp signaling by 
promoting degradation of phosphorylated Smad (Sheng et al. 2010; Shimono et al. 
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2011), further substantiating our finding that RA integrates with Bmp signaling via 
regulation of Bmp’s downstream effectors.   
Loss of rargb results in laterality defects of the liver, heart, and gut, but it is 
unclear whether all defects are linked.  Gut looping occurs around 30 hpf (Horne-
Badovinac et al., 2003), but we observe heart jogging defects as early as 26 hpf; 
accordingly, abnormal LPM migration can only account for visceral organ but not heart 
defects.  It is possible that aberrant RA signaling affects both LPM migration and local 
Bmp signaling around the cardiac cone, thereby affecting multiple organs.  It has 
recently been shown that zebrafish RARs often act as transcriptional activators rather 
than repressors (Waxman and Yelon, 2011), so it is also possible that rargb may 
preferentially activate another molecule on the right side that normally acts as a 
repressor of the hepatic fate.  Ntl, flh, and sur mutants display midline hearts, loss of gut 
looping, and duplication of visceral organs, and it has been suggested that because 
these are loss-of-function mutations, the normally asymmetric liver results from 
suppression of hepatic activators on the right side (Chen et al., 2001).  A previous study 
suggests that rargb is asymmetrically expressed in the neural crest cells of the hindbrain 
at 18 hpf (Linville et al., 2009), however rargb appears to be expressed equally on both 
left and right sides of the trunk during somitogenesis (Figure 2-12C), so it remains 
unclear how rargb exerts its affect on visceral organ laterality.  It is possible that in situ 
hybridization is not sensitive enough to detect slight asymmetries in rargb expression 
that may impact downstream signaling.   
 Organ laterality and bile duct defects exhibited by rargb morphants are 
reminiscent of the human pathological condition right atrial isomerism in which patients 
display midline hearts, midline or duplicated livers, biliary atresia, and asplenia.  Our 
data suggest that perturbed RA signaling may play a role in human heterotaxia and 
furthermore, that heterotaxia can result from mutations in genes other than Nodal.  We 
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demonstrate that loss of Rargb and Bmp overexpression result in the same organ 
laterality defects, where Rargb functions upstream of Bmp signaling to regulate organ 
position, and that Rargb also impacts biliary development.  Biliary abnormalities often 
result in obstructed bile flow, leading to pancreatitis and jaundice, and necessitate 
surgical intervention or liver transplantation in infants (Davenport, 2005; Haber and 
Russo, 2003).  The etiology of biliary atresia remains unknown, but the fact that rargb 
morphants and left/right atrial isomerism patients develop organ situs and biliary defects 
suggests a common underlying mechanism.  By understanding the role of RA and Bmp 
signaling in organ development and positioning, we may be able to better understand 
and treat patients with these life-threatening malformations. 
 
METHODS 
Zebrafish husbandry 
Zebrafish were maintained according to IACUC protocols.  LF2.8-EGFP (referred to as 
Lfabp:GFP) (Her et al., 2003), cmlc2:GFP (Huang et al., 2003), cyp26a1:eYFP (Hu et 
al., 2008), miles apart (mil) (Kupperman et al., 2000), hs:bmp2b (Chocron et al., 2007), 
BRE:eGFP (Laux et al., 2011) and tp1bglob:eGFP (Parsons et al., 2009) transgenic and 
mutant lines have been described previously. 
 
Chemical exposures 
Zebrafish embryos were exposed to 0.1 uM all trans retinoic acid (ATRA, Sigma), 1.0 uM 
4-diethylaminobenzaldehyde (DEAB, Sigma), 1.0 uM AGN193109 (Toronto Research 
Chemicals), 1.0 uM MM11253 (Tocris), 25 uM dorsomorphin, or 0.1 uM CD1530 (Tocris) 
during the specified time windows. Stock solutions were diluted in E3 embryo water.  
Control embryos were concurrently exposed to 0.1% DMSO.  After chemical exposure, 
embryos were washed 3-5x in E3 solution then fixed with 4% PFA at the appropriate 
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stages.  The chemical genetic screen was performed as described previously (North et 
al., 2007).  Wild type age-matched embryos were arrayed into 48-well plates and 
exposed to test compounds from 18-72 hpf.  Compound libraries used include the 
NINDS Custom Collection (1,040 compounds), SpecPlus Collection (960) and BIOMOL 
ICCB Known Bioactives (480). 
 
Whole mount in situ hybridization 
Zebrafish embryos were fixed in 4% PFA at the specified stages, and in situ 
hybridization was performed according to established protocols 
(http://zfin.org/ZFIN/Methods/ThisseProtocol.html) using the following probes: 
(Endoderm) lfabp, prox1, foxA3, shh; (heart) cmlc2, amhc, vmhc; (spleen) hox11; 
(kidney) slc20a1a, slc12a3; (thyroid) nkx2.1a; (LPM) hand2; (Nodal) spaw, pitx2, lefty1, 
lefty2; (Bmp) smad1, smad4, smad 5.  The number of embryos displaying a particular 
phenotype is presented as a percentage of the sample size, n.  
 
Whole mount immunostaining 
BrdU: Zebrafish embryos were incubated in 10 mM BrdU on ice for 20 minutes at 24 hpf, 
returned to warm embryo water for 5 minutes, then fixed in 4% PFA.  Embryos were 
incubated with anti-BrdU primary (Roche) and goat anti-mouse peroxidase-conjugated 
secondary (Jackson ImmunoResearch) antibodies and visualized with DAB. BrdU+ cells 
were counted manually in a defined region of the embryo (n=5 embryos/chemical 
treatment).  
2F11: Zebrafish larvae were fixed at 5 dpf and incubated in a 1:500 dilution of mouse 
monoclonal 2F11 primary antibody (Abcam) followed by 1:50 FITC rabbit anti-mouse 
IgG secondary antibody (Jackson ImmunoResearch). 
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Morpholino knockdown and mRNA rescue injections 
Morpholinos (MOs; GeneTools) were designed against zebrafish raldh2 (5’ 
CAACTTCACTGGA GGTCATCGCGTC 3’) (100 uM) and raldh4 (5’ 
GATATTTCATGTCTTTTGACATCGC 3’) (200 uM), and previously published MOs were 
used against RA receptors raraa, rarab, rarga, and rargb (400-800 uM) (Linville et al., 
2009).  For the RARγ rescue experiment, 200 pg mouse Rarg mRNA (OriGene 
Technologies) was co-injected with 400 uM rargb MO at the 1-cell stage. 
 
Flow cytometry analysis 
Lfabp:GFP fluorescent embryos were exposed to chemicals or injected with MOs as 
described above, whole embryos were manually dissociated in 0.9x PBS, and %GFP+ 
cells were determined by flow cytometric analysis. ≥20,000 cells were analyzed per 
embryo, and ≥5 embryos were analyzed for each chemical treatment or MO injection 
using FlowJo software. 
 
Microscopy 
Live fluorescence microscopy was performed on cmlc2:GFP, BRE:eGFP, or 
tp1bglob:eGFP embryos anesthetized in 0.04 mg/ml Tricaine in E3 embryo water using 
a Zeiss Discovery V8 microscope. Once sorted by phenotype, embryos were washed 
several times and returned to E3 for further observation and/or until fixation.  Embryos 
used in in situ hybridization or BrdU immunostaining experiments were visualized in 
glycerol.  Confocal microscopy of 2F11 immunostained embryos was performed on a 
Zeiss LSM 510 Meta microscope.  For each treatment group, images presented are 
shown at the same magnification.  Scale bars represent 100 microns unless otherwise 
noted. 
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Smad Western blots 
Protein lysates were isolated at 18 hpf from control, rargb morphant, and dorsomorphin-
treated embryos by manual disruption in RIPA buffer.  1:1000 anti-pSmad/1/5/8 (Cell 
Signaling Technology) or 1 ug/ml anti-Smad 1/5/8/9 (Cayman Chemical) primary 
antibody was used, followed by 1:3000 anti-rabbit HRP secondary antibody (Abcam). 
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ABSTRACT 
Exposure to environmental estrogens has increased dramatically over the past 
decade and is correlated with hepatic dysfunction and cancer.  In a chemical genetic 
screen in zebrafish, we identified estrogen as a negative regulator of hepatogenesis.  
Embryos treated with estradiol develop fewer hepatoctyes, resulting in a small liver 
phenotype.  Genetic knockdown of each of the three estrogen receptors revealed that 
embryonic estrogen signaling exerts its effect through the Esr2 receptor subtype.  
Estradiol exposure does not impact the hepatoblast progenitor population, and 
endogenous estrogen levels are reduced concomitant with the initial appearance of 
differentiated hepatocytes, suggesting that estrogen signaling prevents hepatoblast 
differentiation rather than specification.  Removal of estradiol from embryo water 
following early exposure results in the delayed appearance of hepatocytes, further 
indicating that estrogen signaling negatively affects hepatic differentiation.  In mammals, 
5α-reductase mutant mice producing excess estrogen develop less differentiated livers 
compared to their wild type siblings.  In addition, in human hepatocytes, the activating 
epigenetic mark H3K4me1 is diminished at the ERβ locus compared to undifferentiated 
embryonic stem cells and endodermal precursors, resulting in reduced expression of 
ERβ.  Together, our findings define a novel role for estrogen signaling in regulating 
hepatic differentiation.
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INTRODUCTION 
The role of sex hormones in reproductive development is well established, 
however the function of estrogens in non-gonadal organogenesis is less understood.  
Exposure to exogenous estrogens has increased dramatically over the past decade 
(Fucic et al., 2012; Waring et al., 2008; Wolstenholme et al., 2011) and is associated 
with liver dysfunction, suggesting that strict control of estrogen signaling is required for 
proper hepatic development and homeostasis. Estrogenic compounds are able to cross 
the placenta (Vandenberg et al., 2007) and may thereby directly impact organogenesis 
during embryonic development, and the liver, being a first-pass metabolic filter, is 
particularly susceptible to toxic estrogenic insult. 
Women taking oral contraceptives are at increased risk for developing hepatic 
adenomas, and there is significant correlation between estrogen exposure in utero and 
carcinogenesis (Giannitrapani et al., 2006; Harris and Waring, 2012; Laronda et al., 
2012).  Cirrhotic men overexpress estrogen receptors (De Maria et al., 2002), further 
suggesting a correlation between unregulated estrogen levels and liver disease.  
Nevertheless, hepatocellular carcinoma (HCC) is more prevalent in males than females 
in both humans and mice (Buch et al., 2008; Kalra et al., 2008; Parkin et al., 2005), and 
administering estrogen to male mice reduces HCC incidence (Kalra et al., 2008; Li et al., 
2012).  These reports suggest that estrogen signaling influences hepatic growth, but 
there is no consensus on the precise role of estrogens during liver development. 
Estrogen hormones including estradiol (E2), the primary physiological estrogen, 
estrone (E1), and estriol (E3) are steroid hormones derived from cholesterol.  Estradiol 
synthesis culminates in conversion of testosterone to E2 by the enzyme aromatase, also 
known as Cyp19a1.  Typically, estrogens bind and activate cytoplasmic estrogen 
receptors (ESRs) that translocate to the nucleus and bind estrogen response elements 
(EREs) at DNA promoters to regulate downstream transcriptional targets (Nelson and 
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Habibi, 2013), although recent studies have also suggested that estrogens can exert 
their cellular effects by non-genomic mechanisms (Thomas, 2012).  Xenoestrogens are 
a class of synthetic compounds that includes plastic monomers, surfactants, and 
pesticides that mimic or inhibit physiological estrogen action (Colborn et al., 1993; 
McLachlan, 2001; Soto et al., 1994).  Xenoestrogens often persist in the environment 
long after their initial use and have thus become major health concerns in recent years 
(Watson et al., 2013).  Bisphenol A (BPA), for example, a polycarbonate compound 
found in plastic water bottles and food can liners, has been linked to a number of human 
diseases including cancer (Vinas and Watson, 2010).  Plant-derived estrogens, or 
phytoestrogens, are found in many soy-based products and also exhibit estrogenic 
activity; their impact on human health has accordingly also been the subject of 
numerous investigations (Brownson et al., 2002; Cornwell et al., 2004; Jeng et al., 2009; 
Jeng and Watson, 2009; Whitten et al., 1995). 
Zebrafish express three cytoplasmic ESRs, esr1, esr2a, and esr2b, which are 
orthologous to mammalian ERα and ERβ (Bardet et al., 2002; Chandrasekar et al., 
2010), and a less well characterized membrane receptor, G-protein coupled receptor 1 
(GPER) (Liu et al., 2009).  Of all adult zebrafish organs, including the ovaries and testes, 
ESRs are most highly expressed in the liver (Chandrasekar et al., 2010), however their 
embryonic expression and function in non-reproductive organs such as the liver has not 
been investigated in detail. 
In zebrafish, hepatic progenitors, first identifiable by prox1 expression at 18 hours 
post fertilization (hpf), aggregate and emerge as a nascent liver bud between 24 and 48 
hpf.  After 48 hpf, the liver starts to function, as hepatoblasts begin to differentiate into 
hepatocytes that express mature markers such as liver fatty acid binding protein (lfabp) 
(Her et al., 2003) and transferrin (Fraenkel et al., 2009).  Members of the hepatic nuclear 
factor (Hnf), Gata, and FoxA families of transcription factors are known to direct hepatic 
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specification and coordinate hepatoblasts' transition into mature hepatocytes (Zaret, 
2002), but nuclear hormone regulation of hepatic development has not been 
characterized as extensively.  Previous studies have demonstrated unique roles for 
individual retinoic acid receptors during hepatogenesis (Garnaas et al., 2012), 
suggesting that nuclear receptors may regulate several diverse aspects of liver 
development. 
 In this report, we elucidate a role for estrogen signaling during hepatic 
differentiation.  We first identified estrogen signaling as a regulator of normal liver 
development through our prior chemical genetic screen (Garnaas et al., 2012).  
Zebrafish treated with estradiol (E2) or xeno- and phytoestrogens from 18-72 hours post-
fertilization (hpf) develop smaller livers at 72 hpf.  The livers of embryos treated with 
estrogenic compounds are rescued by co-treatment with fulvestrant, an estrogen 
receptor (ESR) antagonist, indicating estrogenic compounds exert their effects via 
ESRs.  Chemical inhibition or genetic knockdown of esr2a and esr2b but not esr1 results 
in bigger livers, demonstrating that the Esr2 receptor subtype governs estrogen’s effect 
on hepatogenesis.  E2 treatment from 18-72 hpf does not significantly impact the 
hepatoblast population, suggesting that E2 does not prevent hepatic specification but 
rather differentiation.  Embryonic estrogen levels decline precipitously from 30-72 hpf, 
thereby allowing liver differentiation to proceed normally.  In mammals, we demonstrate 
that srd5a1 mutant mice that synthesize excess estrogen in utero develop less 
differentiated livers compared to their wild type siblings, confirming the negative impact 
of estrogen on liver maturation.  Furthermore, we find that H3K4 methylation is 
significantly diminished at the ERβ locus in human hepatocytes compared to 
undifferentiated embryonic stem or pan-endodermal cells.  RNA-seq transcriptome 
analysis of these cell populations confirms that the ERβ locus is not highly expressed in 
differentiated human liver cells, and the E2-degrading enzyme Cyp1a is upregulated 
	   77	  
while the E2-synthesizing enzyme Cyp19a1 is downregulated in mature hepatocytes.  
Together, our results demonstrate that endogenous estrogen is under strict temporal 
control to prevent hepatoblasts' differentiation into hepatocytes.	  
 
RESULTS 
Estrogen signaling negatively impacts embryonic liver development 
We previously performed a chemical genetic screen to identify novel regulators 
of liver development (Garnaas et al., 2012) and uncovered seven estrogen-related 
compounds that affect hepatogenesis (Figure 3-1).  Physiological estrogens 17β-
estradiol (E2) and estriol, synthetic estrogens 17α-ethynylestradiol (EE) and 
diethylstilbestrol, and the phytoestrogen quercetin decreased liver size, whereas the 
aromatase inhibitor chrysin and estrogen receptor antagonist tamoxifen increased liver 
size, suggesting that estrogen signaling negatively impacts liver growth. 
To substantiate our chemical screen findings, we treated wild type and lfabp:GFP 
transgenic reporter embryos with 1 uM E2 from 18-72 hpf and consistently noted small 
or absent livers by lfabp in situ hybridization (67/74) and fluorescence microscropy 
(37/42), respectively (Figure 3-2, A-D).  It has previously been determined that this is a 
non-toxic dose that does not impact gross embryo morphology (Chandrasekar et al., 
2010).  We confirmed these findings by examining expression of transferrin, another 
hepatocyte marker; its expression is also reduced in E2-exposed embryos (33/35) 
(Figure 3-3, A-B), demonstrating that E2's negative effect on liver development is not 
specific to lfabp expression.  Shorter (6 or 24 hour time window) E2 exposures between 
18 and 72 hpf similarly inhibited liver formation (Figure 3-3, E-H), suggesting that hepatic 
progenitors are highly sensitive to estrogen over the course of embryonic liver 
development.  Embryos exposed to the xenoestrogen bisphenol A (BPA) (48/51) or 
the phytoestrogen genistein (27/33) also develop smaller livers, whereas exposure to  
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Figure 3-1.  A chemical genetic screen identifies estrogen signaling as a negative 
regulator of embryonic zebrafish liver development. 
(A) Chemical genetic screen workflow.  Wild type (WT) or lfabp:GFP transgenic reporter 
fish were exposed to individual compounds from a library of 2640 known bioactives over 
the course of embryonic liver development (18-72 hpf).  Alterations in liver size were 
detected by fluorescence microscopy and in situ hybridization for lfabp.   
(B) Seven compounds were identified in the screen. Estrogenic compounds 17β-
estradiol (E2), estriol (E3), 17α-ethynylestradiol (EE), diethylstilbestrol, and quercetin 
decreased liver size, whereas the aromatase inhibitor chrysin and estrogen receptor 
antagonist tamoxifen increased liver size. 
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Figure 3-2.  Estrogen signaling negatively impacts embryonic liver development. 
(A-D) Compared to DMSO-treated controls, embryos exposed to estradiol (E2) from 18-
72 hpf develop smaller livers at 72 hpf as determined by in situ hybridization for the 
hepatocyte marker lfabp (A, B) and live fluorescence microscopy of lfabp:GFP 
transgenic reporter fish (C,D). 
(E-H) Dual transgenic ERE:GFP;Lfabp:dsRed reporter fish exposed to E2 display 
activated estrogen signaling in the liver (F) which occurs concomitantly with a smaller 
liver (H) at 72 hpf. 
(I) FACS quantification of percent GFP+ cells in chemically treated lfabp:GFP embryos 
reveals that E2-treated embryos contain fewer hepatocytes than DMSO-treated controls. 
(J) E2 exposure results in a three-fold increase in endogenous E2 concentrations at 30 
hpf as determined by enzyme immunoassay. 
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Figure 3-3.  Estrogen exposure inhibits liver development. 
(A-D) In situ hybridization for the hepatocyte marker transferrin at 72 hpf.  Embryos 
exposed to E2 from 18-72 hpf develop smaller livers (B), whereas exposure to 
anastrozole, an aromatase inhibitor (C), or fulvestrant, an ESR antagonist (D), enhances 
liver development compared to controls (A). 
(E-H) Lfabp:GFP transgenic embryos treated with E2 during shorter exposure windows 
develop smaller livers compared to control siblings at 72 hpf. 
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testosterone (2/18) or progesterone (5/31) does not significantly impact liver 
development (Figure 3-4, A-F), indicating the inhibitory effect is specific to estrogenic 
compounds.  Exposing embryos to anastrozole, an aromatase inhibitor, results in the 
development of bigger livers (28/39) (Figure 3-3C), further illustrating the negative 
impact of estrogen on hepatogenesis.  Using a bigenic estrogen response element 
(ERE) (Gorelick and Halpern, 2011) and hepatocyte transgenic reporter line 
ERE:GFP;lfabp:dsRed, we observed greater GFP fluorescence in the liver primordium of 
embryos treated with E2 from 18-72 hpf (Figure 3-2, E-H), demonstrating that the liver is 
estrogen responsive, and E2 exposure increases estrogen signaling in the liver.  To 
substantiate this finding, we performed an enzyme immunoassay for endogenous 
estrogen levels at 30 hpf.  Estrogen exposure from 18-30 hpf approximately triples the 
endogenous estrogen concentration compared to DMSO controls (Figure 3-2J), 
indicating that exogenous estrogen exposure alters the bioavailability of estrogen in the 
embryo within the physiological range.   
To determine whether changes in liver size correspond to changes in hepatocyte 
cell number, we performed FACS quantification of lfabp:GFP reporter fish at 72 hpf.  
Compared to DMSO-treated control siblings (1.32±0.37% GFP+), we observed a 70% 
decrease in hepatocytes in E2-treated embryos (0.41±0.36% GFP+, p<0.001) compared 
to controls (Figure 3-2I), while liver cell size, as determined by forward and side scatter, 
was not affected.  These results demonstrate that estrogen signaling negatively impacts 
embryonic liver development by reducing the number of hepatocytes. 
 
Estrogen exerts its effect on liver development via Esr2 
To determine whether estrogen exerts its negative effect on hepatogenesis via its 
nuclear receptors, we treated lfabp:GFP embryos with fulvestrant, an estrogen receptor 
(ESR) antagonist from 18-72 hpf.  Compared to control siblings, fulvestrant treated  
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Figure 3-4.  Non-physiological estrogens exert their effect on liver development 
via ESRs. 
(A-F) Embryos exposed to the phytoestrogen genistein (B) and the xenoestrogen 
bisphenol A (BPA) (E) from 18-72 hpf develop smaller livers compared to control siblings 
(A).  Androgen exposure does not impact liver development as demonstrated by normal 
lfabp expression in progesterone (C) and testosterone-treated (F) embryos.  
(G-L) Liver development is rescued in lfabp:GFP embryos co-treated with estrogenic 
compounds E2, BPA, or genistein and the ESR antagonist fulvestrant (Fulv). 
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embryos displayed a marked increase in liver size (35/47).  Furthermore, co-treating 
embryos exposed to E2, BPA, or genistein with fulvestrant rescues the small liver 
phenotype (Figure 3-4, G-L; Figure 3-5, A-C), suggesting that all estrogenic compounds 
examined exert their effects on liver development via ESRs.   
The zebrafish expresses three ESRs: esr1, an ortholog of mammalian ERα, and 
esr2a and esr2b, duplicated orthologs of mammalian ERβ.  In situ hybridization for the 
three cytoplasmic zebrafish ESRs reveals that Esr2a is expressed in the area of the liver 
primoridum at 72 hpf (Figure 3-6), suggesting that the Esr2 isoform is responsible for 
mediating estrogen's effect on liver development.  All three zebrafish ESRs are 
expressed prior to the midblastula transition indicating that they are originally maternally 
deposited, and they continue to be expressed to varying degrees throughout embryonic 
development (Bardet et al., 2002; Tingaud-Sequeira et al., 2004).  To further elucidate 
which receptors impact liver size, we exposed embryos to specific ESR agonists and 
antagonists from 18-72 hpf and scored lfabp expression at 72 hpf.   Embryos treated 
with the Esr2 agonist DPN develop smaller livers (100/113), while the Esr1 agonist 
PPT has no effect (91/101 normal).  Conversely, embryos exposed to the Esr2 
antagonist PHTPP develop bigger livers (30/33), whereas the Esr1 antagonist MPP 
has a lesser effect (35/46 normal) (Figure 3-5, D-I).  
To confirm our chemical exposure results genetically, we knocked down ESRs 
individually and in combination using antisense morpholino (MO) technology and 
assessed liver development at 72 hpf.  Knockdown of esr2a (15/105) or esr2b 
(30/100) results in bigger livers while loss of esr1 has no effect (5/70) compared to 
controls (Figure 3-5, J-M).  Double receptor knockdown of esr2a+2b resulted in a greater 
proportion of embryos with enlarged livers (45/100) than any individual receptor 
knockdown alone (Figure 3-5N), further indicating that the Esr2 subtype governs 
estrogen's effect on liver development.  In addition, whereas E2 exposure alone  
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Figure 3-5 (next page).  Estrogen exerts its effect on liver development via Esr2 
receptors. 
(A-C) Lfabp:GFP embryos exposed to E2 (B) develop smaller livers compared to 
controls (A), whereas liver size is rescued in embryos co-treated with E2 and the ESR 
antagonist fulvestrant (E2+Fulv) (C). 
(D-I) Embryos exposed to the Esr1 agonist PPT (E) and Esr1 antagonist MPP (H) from 
18-72 hpf develop normal livers at 72 hpf compared to DMSO-treated controls (D) as 
determined by lfabp in situ.  In contrast, embryos exposed to the Esr2 agonist DPN (F) 
develop small livers, and embryos exposed to the Esr2 antagonist PHTPP (I) develop 
larger livers compared to controls. 
(J-M) Morpholino (MO) knockdowns of esr2a and esr2b result in bigger livers at 72 hpf 
(L, M), while loss of esr1 has little effect on liver size (K) compared to controls (J). 
(N) Quantification of individual and double ESR knockdowns.  Knockdown of esr2a and 
esr2b in combination results in a greater percentage of embryos with larger livers than 
that of each ESR knockdown alone.  Liver size is partially rescued in esr2a and esr2b 
morphant embryos challenged with E2 from 18-72 hpf. 
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Figure 3-5 (continued) 
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Figure 3-6.  Esr2a is expressed in the liver primordium. 
(A-C) Expression patterns of esr1, esr2a, and esr2b at 72 hpf by in situ hybridization. 
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results in small or absent livers, a proportion of E2-treated embryos injected with esr2 
MOs are protected against E2's negative effects (Figure 3-5N).  These results indicate 
that exogenous estrogens negatively impact liver development, and their effect is 
mediated via Esr2 isoforms.  Moreover, the fact that loss of esr2a and esr2b results in 
larger livers in the absence of exogenous estrogen suggests that endogenous estrogen 
is normally required to limit liver growth or maturation in the embryo, and this regulation 
is similarly achieved through the Esr2 receptor subtype.  
 
E2 exposure prevents hepatoblasts from differentiating into hepatocytes 
To determine whether the small or absent liver phenotype of E2-exposed 
embryos results from hepatoblast depletion or impaired differentiation into hepatocytes, 
we treated lfabp:GFP embryos with E2 from 18-72 hpf, removed E2 at 72 hpf,  then 
followed liver development in individual embryos from 72-120 hpf using live fluorescence 
microscopy (10 embryos/treatment) (Figure 3-7, A-F).   At 72 hpf, 100% of E2-exposed 
embryos display small or absent livers.  At 96 hpf, 60% of embryos’ livers show 
enhanced fluorescence indicative of recovery, and by 120 hpf, 80% of the embryos have 
livers that have recovered to normal size.  These data suggest that estrogen exposure 
does not deplete the hepatic progenitor population but rather prevents hepatoblasts from 
differentiating into mature hepatocytes.  To directly demonstrate that estrogen exerts 
different effects on hepatoblast and hepatocyte populations, we treated embryos with 
DMSO or E2 from 18-72 hpf and assessed expression of hepatoblast (prox1) and 
hepatocyte (lfabp) markers at 72 hpf by in situ hybridization.  E2 exposure does not 
impact hepatic progenitors but results in a loss of mature hepatocytes (Figure 3-7, H-K).  
We also performed chemical treatments during shorter, earlier time windows (18-24 and 
24-48 hpf) and examined prox1 expression at each exposure's end point (24 and 48 hpf, 
respectively) and lfabp at 72 hpf since it is not expressed earlier.  In all cases, prox1 
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Figure 3-7 (next page).  Estrogen inhibits hepatoblast differentiation into 
hepatocytes. 
(A-F) Livers of lfabp:GFP embryos exposed to E2 from 18-72 hpf (D-F) recover to 
control liver size (A-C) by 120 hpf after E2 removal at 72 hpf. 
(G) Endogenous E2 levels (pg/ml) as quantified by enzyme immunoassay.  E2 
concentration declines between 30 and 72 hpf, concurrent with hepatocyte 
differentiation. 
(H-K) In situ hybridization for the hepatoblast marker prox1 (H, J) and the hepatocyte 
marker lfabp (I, K) at 72 hpf.  Lfabp expression is lost in embryos treated with E2 from 
18-72 hpf (K), however prox1 expression remains unchanged (J) compared to DMSO-
treated controls (H, I). 
(L) Embryos treated with E2 during 18-24, 24-48, or 18-72 hpf exposure windows 
develop small or absent livers as determined by lfabp at 72 hpf, whereas the prox1+ 
hepatoblast population remains largely unaffected by E2 treatments.  Embryos assayed 
for lfabp expression were stopped at 72 hpf, whereas embryos assayed for prox1 
expression were stopped at the end of each exposure window. 
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Figure 3-7 (continued) 
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expression was unaffected by E2 exposure, whereas lfabp expression was diminished or 
absent (Figure 3-7L).  These data further indicate that estrogen does not impact the 
nascent hepatoblast population but inhibits their differentiation into hepatocytes.   
Given estrogen's ability to inhibit hepatocyte differentiation, we quantified 
endogenous levels of E2 over the course of embryonic liver development to establish 
whether changes in E2 levels correlate with hepatic differentiation.  Using an enzyme 
immunoassay, we determined that endogenous E2 levels rise between 24 and 30 hpf 
(Figure 3-7G), likely due to the onset of embryonic estrogen synthesis following 
depletion of maternal deposits, as expression of the zebrafish aromatase gene 
cyp19a1b increases between 24-48 hpf (Mouriec et al., 2009).  Levels of endogenous 
estrogen then decline precipitously until E2 is no longer detectable at 72 hpf.  The 
decline of endogenous estrogen occurs concomitantly with the timing of hepatocyte 
maturation and proliferation, suggesting that endogenous estrogen may act to prevent 
hepatoblasts from differentiating into hepatocytes too early or before liver function is 
required.  Expression of the estrogen-degrading enzyme cyp1a increases after 72 hpf 
(Jones et al., 2010), indicating one mechanism by which E2 levels are downregulated.  
In addition, aromatase/cyp19a1b contains an ERE in its promoter (Tong and Chung, 
2003) and is upregulated in the presence of excess estrogen (Cheshenko et al., 2007), 
suggesting reduced endogenous estrogen levels also moderate this autoregulatory 
feedback loop. 
 
E2 exposure affects hepatic differentiation in mammals 
To determine whether estrogen's effect on hepatic differentiation in zebrafish is 
conserved in mammals, we examined embryonic liver development in 5α-reductase 
mutant mice (Srd5a1-/-) (Mahendroo et al., 1997).  During androgen and estrogen 
biosynthesis, testosterone is converted irreversibly into either dihydrotestosterone by 5α-
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reductase or estradiol by aromatase.  Loss of 5α-reductase results in a metabolic 
imbalance in which excess estradiol is produced.  We compared fetal livers of mutant 
and wild type siblings at E14.5 since hepatoblasts normally begin to differentiate into 
mature hepatocyte and biliary lineages by E13.0 (Crawford et al., 2010).  We found that 
mutant livers are less organized than wild type controls as determined by H&E stain 
(Figure 3-8, A-B), suggestive of a less differentiated, immature liver. We also performed 
immunohistochemistry to determine whether expression of hepatic markers alpha-
fetoprotein (AFP), hepatic nuclear factor 4α (HNF4α), and albumin (Alb) was altered in 
Srd5a1-/- embryos.  The murine liver is specified by E9.0, at which time hepatoblasts 
begin to express AFP and HNF4α (Crawford et al., 2010).  Whereas AFP expression 
diminishes from E9.0 onwards (Hata et al., 2007), Alb, the predominant marker of 
mature hepatocytes, begins around E12.0 and increases into adulthood (Tilghman and 
Belayew, 1982).  We noted marked increases in HNF4α and AFP expression in mutant 
livers at E14.5 (Figure 3-8, C-F), but there was no difference in Alb expression at this 
timepoint (data not shown).  These results further underscore that Srd5a1 mutant livers 
are less differentiated than their wild type siblings' given the greater and persistent 
expression hepatic progenitor markers.   
In addition to elucidating the effect of excess estrogen on mouse hepatic 
development, we examined epigenetic modifications on human ERα and ERβ coding 
sequences in human cells.  We specifically investigated epigenetic changes at these loci 
in pluripotent embryonic stem cells (ESCs), differentiated endodermal cells, and mature 
hepatocytes to determine whether modifications accompany cell differentiation.  The 
pattern of H3K4 methylation (H3K4me1), an activating histone mark, remained relatively 
unchanged at the ERα locus across all cell types (Figure 3-9A).  In contrast, H3K4me1 is 
significantly diminished at the ERβ locus in hepatocytes compared to undifferentiated  
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Figure 3-8 (next page).  Srd5a1 mutant mouse livers are less differentiated than 
wild type sibling controls. 
(A, B) H&E staining of sectioned mouse livers at E14.5.  Srd5a1 -/- livers (B) are less 
organized and compact and contain more hepatoblasts than wild type sibling livers (A).   
(A',B') Magnifications of the boxed areas in (A, B).  Boxed area in B' highlights an 
immature hepatoblast. 
(C-F) Immunohistochemistry for hepatic markers HNF4α (C, D) and alpha-fetoprotein 
(AFP) (E, F) demonstrates that Srd5a1 -/- mice retain more hepatoblasts than wild type 
livers at E14.5.  
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Figure 3-8 (continued) 
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Figure 3-9 (next page).  Estrogen receptors are downregulated during hepatic 
differentiation. 
(A) Histone methylation changes at the human estrogen receptor ERα and ERβ loci 
during embryonic stem cell differentiation.  The activating methylation mark H3K4me1 is 
lost at the ERβ locus in mature hepatocytes. 
(B) RNA expression values of estrogen signaling pathway components and hepatic 
markers in ESCs (teal), endoderm (purple), hepatoblasts (yellow), and hepatocytes 
(green).  Expression values were measured as fragments per kilobase of exon per 
million fragments mapped (FPKM).  
(C) Changes in expression of zebrafish esr1, esr2a, and esr2b in foxA3+ endodermal 
cells at 2 and 4 dpf. 
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Figure 3-9 (continued) 
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ESCs or endodermal cells (Figure 3-9A), and this epigenetic change correlates with 
decreased expression of ERβ (Figure 3-9B).  RNA-seq transcriptome analyses of all cell 
types also revealed that the E2-degrading enzyme Cyp1a2 is augmented and the E2-
synthesizing enzyme Cyp19a1/aromatase is reduced in hepatocytes compared to 
expression levels in less differentiated precursors (Figure 3-9B), further demonstrating 
that estrogen signaling is downregulated in differentiating liver cells.  Expression of 
known hepatic markers Albumin (Alb), Hhex, and HNF4α confirmed cell type identity 
(Figure 3-9B) and corroborate our mouse data indicating that Srd5a1-/- mutant livers 
improperly overexpress hepatoblast markers (Figure 3-8, C-F).  The fact that ERβ 
expression is downregulated in hepatic cells substantiates our hypotheses that estrogen 
signaling functions via Esr2/ERβ and normally functions as a negative regulator of 
hepatoblasts' differentiation into hepatocytes.  
To determine whether zebrafish not only downregulate the estrogen ligand but 
also ESR expression during hepatic differentiation, we analyzed publicly available 
microarray profiles of FACS-sorted endodermal (foxA3+) cells (Stuckenholz et al., 2009) 
between 2 and 4 dpf.  We found that there is a general trend of decreased ESR 
expression between these stages, which coincides with the timing of hepatic 
differentiation.  In particular, both esr1 and esr2b expression is reduced between 2 and 4 
dpf in zebrafish, while esr2a expression remains relatively unchanged (Figure 3-9C).  
These data demonstrate that ESR expression is modulated in endodermal tissues during 
liver development and align with our findings that estrogen signaling is downregulated 
concomitant with hepatocyte differentiation.  Given that the Esr2 subtype regulates 
embryonic hepatogenesis, reduced expression of esr2b after 2 dpf may act to further 
mitigate estrogen's inhibition of hepatic differentiation.  Although we do not find that Esr1 
contributes significantly to liver development, its reduced expression may be indicative of 
declining levels of endogenous E2, as an ERE has been identified in the promoter region 
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of Esr1 in zebrafish (Menuet et al., 2004).  Collectively, our data identify a regulatory role 
for the Esr2/ERβ subtype in embryonic liver differentiation across species. 
 
DISCUSSION 
 In this report, we identified estrogen signaling as a negative regulator of 
embryonic liver development and demonstrated that estradiol (E2) exerts its effects via 
the estrogen receptor 2 (Esr2) subtype.  Removal of E2 following embryonic exposure 
results in the delayed appearance of hepatocytes, however embryos ultimately form a 
normal-sized liver.  Exposure to E2 does not impact the prox1+ hepatoblast population, 
indicating that hepatic progenitors remain in the presence of estrogen and retain their 
ability to differentiate into mature hepatocytes.  Assessment of endogenous E2 levels 
revealed that downregulation of E2 by 72 hpf occurs concomitantly with hepatic 
differentiation.  Mammalian studies corroborate our zebrafish findings: in mice, excess 
estrogen results in an undifferentiated liver phenotype, and in human cells, differentiated 
hepatocytes show reduced ERβ expression relative to undifferentiated ESCs, 
endodermal cells, and hepatoblasts. 
 The zebrafish expresses three ESRs – Esr1, orthologous to mammalian ERα, 
and Esr2a and Esr2b, which resulted from a zebrafish genome duplication event and are 
each equally related to mammalian ERβ (Bardet et al., 2002).  It is clear that mammalian 
ERs exert distinct biological functions as differences in receptor expression patterns and 
knockout phenotypes are well documented in mice (Harris, 2007; Zhao et al., 2008).  In 
humans, ERα binds E2 with four times greater affinity than ERβ, and it is considered the 
primary mediator of estrogen's effects on classical target tissues such as the 
reproductive organs, mammary glands, skeleton, and hypothalamus (Harris, 2007; 
Hawkins and Thomas, 2004).  Interestingly, in a number of fish species including Danio 
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rerio, Esr2 binds E2 with higher affinity than Esr1 (Menuet et al., 2002; Xia et al., 2000), 
suggesting that Esr2 receptor may be the primary mediator of estrogen signaling in 
teleosts. 
 Using an enzyme immunoassay to quantify endogenous E2 concentrations in 
zebrafish, we uncovered a significant drop in estrogen levels after 30 hpf, corresponding 
to the onset of hepatocyte differentiation.  In human cells, we determined that there are 
fewer activating H3K4 methylation marks at the ERβ locus in hepatic cells, similarly 
demonstrating that reduced estrogen signaling is required for hepatocyte differentiation.  
A recent study demonstrated that zebrafish embryos exposed to E2 at 3 and 4 dpf show 
reduced expression of lfabp (fabp10a) compared to earlier timepoints (Hao et al., 2013), 
validating our results that demonstrate that estrogen has a negative effect on 
differentiating hepatocytes.  Together, our results suggest that zebrafish and mammals 
accomplish hepatic differentiation via similar mechanisms – both downregulate ESR/ER 
expression, and zebrafish additionally downregulate the estradiol ligand.  ESR 
expression has been shown to increase in response to E2 exposure (Chandrasekar et 
al., 2010), suggesting that the estrogen ligand mediates receptor expression in an 
autoregulatory feedback loop.   Expression of cyp1a, an E2-degrading enzyme, has 
been shown to markedly increase between 72 and 96 hpf (Jones et al., 2010), 
suggesting that this may be one of the primary temporal mechanisms by which E2 levels 
are abated.  By decreasing global levels of E2, the embryo may thereby also 
downregulate receptor expression to ensure proper signaling levels during development.  
An estrogen response element (ERE) has been identified in the promoter region of ERα 
in rainbow trout (Le Drean et al., 1995) and an imperfect ERE site found in Esr1 in 
zebrafish (Menuet et al., 2004).  Mammalian embryos develop in utero and are therefore 
continuously exposed to factors in their mother's circulation, so downregulating ERs 
rather than the estrogen ligand may be the most effective mechanism to control 
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embryonic estrogen signaling activity.  Conversely, teleosts are externally fertilized and, 
excepting initial deposition of maternal factors in the yolk, must regulate their 
development independently; this may explain why zebrafish employ redundant 
mechanisms to regulate estrogen signaling.   
Exogenous estrogen treatment inhibits hepatocyte differentiation, and hepatocyte 
differentiation naturally corresponds with diminishing levels of endogenous E2 in the 
embryo.  It is conceivable that the embryo normally uses estrogen signaling as a means 
to prevent liver differentiation from occurring too early, as this could have deleterious 
effects on development.  For example, premature differentiation may reduce the number 
of specified hepatic progenitors and consequently the pool of mature hepatic cell types.   
In addition, creating an organ before its function is required would result in unnecessary 
energy expenditure that may prove detrimental to a newly formed embryo's continued 
growth and survival.   
Given ESRs' roles as transcriptional activators, it is possible that estrogen 
activates downstream factors responsible for establishing or maintaining the hepatoblast 
population.  In ESC-derived endoderm, continuous expression of Hex leads to 
decreased levels of the hepatocyte marker Albumin, suggesting that prolonged Hex 
expression inhibits hepatic differentiation (Kubo et al., 2010).  Uncovering the 
downstream targets of estrogen signaling in liver development will not only be crucial to 
understanding how estrogen exerts its inhibitory effects on hepatogenesis but may aid 
our understanding of hepatoblastoma, a malignant liver cancer that contains proliferating 
hepatic progenitors. Overexpression of a number of growth factors including IGF and c-
MET is correlated with less differentiated tumors (Kim et al., 2005; Akmal et al., 1995; 
von Schweinitz et al., 2002), so it would be informative to assess estrogen regulation in 
this setting. 	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Our finding that human ERβ undergoes epigenetic modification during hepatic 
differentiation suggests that chromatin remodeling is an important aspect of embryonic 
organogenesis and furthermore, that aberrant methylation may contribute to 
developmental defects and adult disease.  The promoter regions of mammalian ERs 
have been shown to be subject to extensive epigenetic regulation, and changes in 
methylation at the ERβ locus have been linked with cancer onset and progression in the 
breast and kidney (Dulaimi et al., 2004; Mirza et al., 2012; Zhao et al., 2008).   
 In addition to elucidating the role for endogenous estrogens during embryonic 
hepatogenesis, we also demonstrated the negative impact of exogenous estrogen 
exposure on the developing liver.  Embryos treated with xeno- or phytoestrogens from 
18-72 hpf display decreased liver size, and this effect is rescued by co-treatment with 
fulvestrant, indicating that these estrogenic compounds also exert their effects via ESRs.  
Steroid hormone receptors have been identified in ancestral non-vertebrate taxonomies 
and are believed to have originated as environmental toxin sensors (Keay and Thornton, 
2009; Paris et al., 2008; Thornton et al., 2003), so it is not surprising that non-
physiological estrogens can act agonistically at ESRs.  In recent years, estrogenic 
compounds have appeared in increasing concentrations in our environment (ethinyl 
estradiol in oral contraceptives, dichlorodiphenyltricloroethane/DDT in insecticides, 
nonylphenol in oil dispersants), plastic products (bisphenol A/BPA), and diet (genistein 
and daidzein in soy), and it is therefore imperative that we continue to explore the effects 
of exogenous estrogen exposure on organ development.  Future investigations into 
estrogen’s role during normal embryonic hepatogenesis will further uncover its 
developmental importance and improve our understanding of liver growth and 
differentiation in disease states. 
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METHODS 
Zebrafish husbandry 
Zebrafish were maintained according to IACUC protocols.  LF2.8-EGFP (referred to as 
lfabp:GFP) (Her et al., 2003), lfabp:dsRed (Korzh et al., 2008), and 5xERE:GFP 
(ERE:GFP) (Gorelick and Halpern, 2011) transgenic lines have been described 
previously. 
 
Chemical exposures 
Zebrafish embryos were exposed to 1 µM E2, 10 µM fulvestrant, 1 µM anastrozole, 20 
µM DPN, 20 µM PHTPP, 20 µM PPT, 20 µM MPP, 5 µM BPA, and 5 µM genistein 
during specified time windows. Stock solutions were diluted in embryo water.  Control 
embryos were concurrently exposed to 0.1% DMSO.  After chemical exposure, embryos 
were washed 3-5x in embryo water then fixed with 4% PFA at the appropriate stages.  
The chemical genetic screen was performed as described previously (Garnaas et al., 
2012).  
 
Whole mount in situ hybridization 
Zebrafish embryos were fixed in 4% PFA at the specified stages, and in situ 
hybridization was performed according to established protocols 
(http://zfin.org/ZFIN/Methods/ThisseProtocol.html) using lfabp, prox1, esr1, esr2a, and 
esr2b probes.  
 
Morpholino knockdown 
Morpholinos (MOs; GeneTools) were designed against zebrafish esr1           
(5' AGGAAGGTTCCTCCAGGGCTTCTCT 3') (20 uM) (Pang and Thomas, 2010), esr2a 
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(5’ ACATGGTGAAGGCGGATGAGTTCAG 3’) (10 uM) (Froehlicher et al., 2009), and 
esr2b (5' AGCTCATGCTGGAGAACACAAGAGA 3') (10 uM) and injected at the 1 cell 
stage.  When injected in combination, MO doses were halved to prevent morphological 
defects due to toxicity. 
 
Flow cytometry analysis 
Lfabp:GFP fluorescent embryos were exposed to chemicals as described above.  Whole 
embryos were manually dissociated in 0.9x PBS, and %GFP+ cells were determined by 
flow cytometric analysis. ≥20,000 cells were analyzed per embryo, and ≥5 embryos were 
analyzed for each chemical treatment using FlowJo software. 
 
Microscopy 
Live fluorescence microscopy was performed on lfabp:GFP and ERE:GFP; lfabp:dsRed 
embryos anesthetized in 0.04 mg/ml Tricaine in embryo water using a Zeiss Discovery 
V8 microscope.  After visual examination, embryos were washed several times and 
returned to embryo water for further observation and/or until fixation.  Embryos used in in 
situ hybridization experiments were visualized in glycerol.  
 
Estradiol immunoassay 
A commercially available estradiol enzyme immunoassay (EIA) kit (Cayman Chemical) 
was used.  Embryos were treated with DMSO or estradiol (E2) as above, and 30 
embryos were pooled at each timepoint for assessment of endogenous estrogen levels. 
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5α-reductase type 1 (Srd5a1) mice  
Female B6;129S7-Srd5a1tm1Mahe/J mice (Jackson Laboratory) from timed heterozygous 
incross matings were sacrificed at E14.5, and embryonic livers were isolated by 
microdissection in 1x PBS and fixed in 4% PFA for histological analyses. 
 
Immunohistochemistry 
Mouse livers were isolated at E14.5, fixed in 4% PFA, embedded in paraffin and 
sectioned.  Alternating sections were H&E stained or used for immunohistochemistry.  
Sections were incubated in 1:1000 HNF4α (Abcam) or 1:100 AFP (Thermo Scientific) 
rabbit anti-mouse primary antibody followed by 1:100 Cy3-conjugated donkey anti-rabbit 
IgG secondary antibody (Jackson ImmunoResearch) and counterstained with DAPI 
(Vector Laboratories).  
 
ESC differentiation, ChIP-seq, and RNA-seq 
Human ESCs were cultured according to published procedures (Bock et al., 2011; De La 
Forest et al., 2011), and ChIP-seq and RNA-seq libraries were prepared and analyzed 
according to established protocols (Gifford et al., 2013; personal communication, 
Alexander Meissner).  Hepatocytes isolated from adults were used in ChIP-seq 
experiments, and hepatocytes differentiated from ESCs were analyzed in RNA-seq 
experiments. 
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CHAPTER 4 
 
Ongoing and Future Work 
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ESTROGEN SIGNALING DURING LIVER DEVELOPMENT 
Estrogen exhibits biphasic effects on liver development 
 In addition to demonstrating the impact of embryonic estradiol (E2) exposure on 
zebrafish liver development (see Chapter 3), we will also examine the effect of estrogen 
signaling on later larval development.  We have preliminary data suggesting that 
estrogen signaling exerts a biphasic effect on hepatogenesis; that is, it inhibits 
embryonic liver development but enhances larval liver development.  As we 
demonstrated previously, E2 treatment from 18-72 hpf leads to a marked decrease in 
liver size and hepatocyte number (Figure 3-2; Figure 4-1, A-C).  Interestingly, E2 
treatment from 120-144 hpf has a positive effect on liver growth at 144 hpf, where 83% 
of embryos (n=54) have bigger livers compared to DMSO-treated controls (Figure 4-1, 
D-F).  FACS quantification of hepatocytes sorted from lfabp:GFP reporter larvae 
confirms that increased liver size is due to a greater number of hepatocytes (1.99±0.37% 
GFP+ control versus 2.8±0.49% E2-exposed embryos).  Larval fulvestrant exposure 
results in embryos with smaller livers (Figure 4-1G), providing further evidence that later 
stage estrogen signaling enhances liver development. 
 To further investigate estrogen's effect on larval liver development, we will 
characterize which cell populations are impacted by E2 exposure from 120-144 hpf and 
identify the molecular mechanisms by which this occurs.  Specifically, we will assess 
whether enhanced liver development in E2-treated larvae is accompanied by changes in 
the hepatic gene program (hhex, prox1, lfabp) by in situ hybridization (ISH) and qPCR 
analyses.  We will evaluate cell viability and proliferation using TUNEL and BrdU assays, 
respectively, and determine whether cell cycle and proliferation markers (cyclin D1, c-
myc) are altered in E2-exposed larvae.  Similar to our study of estrogen's role in 
embryonic liver development, we will also elucidate the contribution of receptor subtypes 
to this phenotype by chemical and genetic modulation.  Finally, we will identify  
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Figure 4-1.  Estrogen signaling exerts a biphasic effect on liver development. 
(A-C) Lfabp:dsRed transgenic reporter embryos exposed to estrogen pathway 
compounds from 18-72 hpf.  Embryos exposed to estradiol (E2) during embryonic 
development develop smaller livers (B) compared to DMSO-treated controls (A).  
Conversely, embryos exposed to the estrogen receptor antagonist fulvestrant develop 
larger livers (C). 
(D-F) Lfabp:dsRed larvae exposed to estrogen pathway compounds from 120-144 hpf.  
In contrast to embryonic exposures, larvae treated with E2 develop bigger livers (E) 
compared to DMSO-treated controls (D).  Fulvestrant exposure does not significantly 
impact liver size (F). 
 (G) FACS quantification of percent GFP+ cells in chemically treated lfabp:GFP larvae 
reveals that zebrafish exposed to E2 from 120-144 hpf contain more hepatocytes than 
DMSO-treated controls. 
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downstream transcriptional targets of the estrogen receptors and compare target genes 
to those identified at embryonic stages (see below). 
 
Identification of downstream transcriptional targets of estrogen signaling 
 The signaling pathways directly impacted by estrogen exposure during liver 
development have not been elucidated, and we have undertaken a ChIP-seq experiment 
to address this gap in knowledge.  Specifically, to identify estrogen receptor targets in 
hepatic progenitors and mature hepatocytes, we performed ChIP-seq on cells isolated 
from 1 and 5 dpf embryos injected with esr2a or esr2b-myc constructs.  These time 
points correspond to embryonic and larval stages during which estrogen exerts alternate 
effects.  As demonstrated in Chapter 3, the Esr2 subtype mediates estrogen's effect on 
early embryonic development (Figure 3-5), so we pursued transcriptional targets of 
Esr2a and Esr2b.  We created Myc-labeled ESRs to pull down estrogen receptor-bound 
chromatin using a Myc antibody, as no Esr2 antibodies exist with sufficient cross-
reactivity to zebrafish, and Myc-based ChIP has been successfully executed in the 
zebrafish (Xu et al., 2012).  Following sequence data analysis, novel estrogen targets 
will be validated by genetic knockdown or overexpression experiments.  We will inject 
target gene MO or mRNA constructs into lfabp:GFP reporter fish to evaluate hepatocyte 
development in live embryos and further corroborate these data with in situ hybridization 
for hepatoblast (prox1, hhex) and mature hepatocyte markers (lfabp, transferrin) at the 
appropriate stages.  If estrogen functions upstream of an identified target, embryos 
injected with a target MO should not respond to E2 treatments during hepatogenesis.  
Conversely, overexpressing the target gene by mRNA injection should mimic the effect 
of estrogen exposure.  We hypothesize that ESRs bind to different target gene 
promoters during embryonic and larval stages, thus facilitating estrogen's biphasic effect 
on liver development.  In conjunction with our investigation in Chapter 3, these studies 
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will further illuminate the role of estrogen signaling during hepatic differentiation and 
outgrowth stages. 
 
NUCLEAR RECEPTOR SIGNALING AND LIVER REGENERATION 
Genetic programs regulating organogenesis in the embryo may be recycled 
during adult tissue repair and regeneration.  The liver is one of a few human organs 
(skin, intestine, blood) that is able to regularly regenerate.  Previous work in the 
laboratory has shown that Wnt signals affecting hepatic progenitor cells in zebrafish 
embryos also govern adult liver regeneration in zebrafish and mouse (Goessling et al., 
2008).  Clinical studies have shown that hepatocyte transplants can reestablish liver 
function following organ failure, however expanding hepatocyte populations in cell 
culture has proven difficult (Zaret and Grompe, 2008).  Our investigation of the role of 
nuclear receptor signaling in adult liver homeostasis may thus have important 
consequences for designing therapeutics for improving liver growth and function 
following trauma associated with liver disease and cancer.   
 
Retinoic acid signaling inhibits liver regeneration 
To investigate the role of nuclear receptor signaling in adult liver regeneration, 
we employ a surgical resection (1/3 partial hepatectomy) model established by the 
laboratory (Goessling et al., 2008).  Liver regeneration studies in mammals suggest an 
antagonistic role for RA signaling in adult tissue repair (Hu et al., 1994; Ozeki and 
Tsukamoto, 1999), and our preliminary studies also indicate this to be the case in 
zebrafish.  In our initial experiment, ATRA treatment following partial hepatectomy 
inhibits liver regeneration, whereas DEAB enhances liver regeneration compared to 
DMSO controls (5 fish/treatment) (Figure 4-2, A-C).  We will repeat these experiments to 
solidify our observations.  We will also test the effect of additional RA pathway  
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Figure 4-2. Retinoic acid and estrogen signaling inhibit liver regeneration 
following partial hepatectomy. 
(A-F) Adult zebrafish liver regeneration capacity was evaluated by measuring the liver 
lobe:remnant ratio following surgical resection and chemical treatment.  Compared to 
DMSO-treated control livers (A), ATRA-treated livers do not regenerate (B), whereas 
DEAB-treated livers show accelerated regeneration (C).  Estradiol (E2) treatment 
caused cessation of liver growth at the resection margin and enhanced growth in the 
remaining lateral liver lobes, whereas fulvestrant treatment did not negatively impact 
liver regrowth (F).  Red arrows indicate the point of resection.  Livers are outlined by 
dotted lines. 
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compounds and analyze heterozygotes from our RA pathway mutant lines neckless and 
giraffe (raldh2 and cyp26a1 mutants, respectively; homozygotes are not viable past 
embryogenesis) to determine whether particular RA pathway members are required 
during adult liver regeneration.  We will analyze histological sections of livers for BrdU 
incorporation to demonstrate whether chemical treatment enhances the proliferative 
response of liver cells following resection and perform TUNEL staining on liver sections 
to evaluate the extent of cell death.  Expression of RA pathway members in the liver will 
be assessed by ISH to determine whether particular genes are required in the 
regenerating tissue.  Together, these experiments will elucidate the impact of RA on 
adult liver regeneration and highlight the continued impact of RA on hepatocyte 
proliferation. 
 
Estradiol differentially affects regenerating and uninjured liver lobes 
 Our preliminary data suggest that adult zebrafish livers exposed to E2 following 
resection are larger overall compared to DMSO-treated controls (n≥10 fish/treatment), 
results that are consistent with liver weight calculations in mouse experiments (Dixit et 
al., 1991).  Interestingly, E2 treatment completely inhibits regrowth at the resection site 
on the lower lobe but results in excess growth in the upper lobes (Figure 4-2, D-F).  In 
addition, the patterning of the hepatic and vascular tissue in the upper lobes is altered 
compared to controls.  We will assess liver regeneration in the presence of various 
modulators of estrogen signaling, with particular interest in addressing the requirement 
for particular receptor subtypes in the regenerative process.  Given E2's disparate effect 
on the resected and upper lobes, we hypothesize that distinct localization of receptor 
subtypes governs this atypical regenerative response.  To further characterize this 
regenerative phenotype, we will also isolate RNA from tissue dissected from the 
resected and upper lobes for analysis of estrogen pathway, cell cycle, hepatic, and 
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vascular genes by qPCR.  Proliferation and cell cycle analyses will be performed as 
described above.  Because levels of circulating estrogen differ between males and 
females, we will stratify all data by gender.  Based on our preliminary results, we expect 
that females will exhibit faster regenerative kinetics relative to males.  These studies will 
inform our understanding of the impact of estrogens, both physiological and 
environmental, on adult liver regrowth. 
 
Assays for liver function 
We anticipate that NR pathway compounds affecting liver regrowth will also 
affect liver function, so we will examine serum protein levels in adult zebrafish following 
surgical resection.  In humans, liver damage can be detected by evaluating serum levels 
of liver-specific enzymes, such as aminotransferases, bilirubin, and alkaline 
phosphatase (Ozer et al., 2008).  Alanine aminotransferase (ALT) is the most frequently 
relied upon marker of hepatotoxicity.  ALT plays roles in amino acid metabolism and 
gluconeogenesis, and its presence in the blood is indicative of hepatocyte damage.  
Bilirubin is a product of hemoglobin degradation, and its presence in the serum is 
suggestive of hepatobiliary defects, such as cholestasis.  Enhanced levels of alkaline 
phosphatase (AP) also indicate hepatobiliary damage (Goessling and Friedman, 2005).  
Following liver resection and chemical exposures, zebrafish blood will be harvested by 
cardiac puncture using microcapillary tubes and serum proteomic analysis will be carried 
out in Dr. Wolfram Goessling’s clinical laboratory.  Liver-specific enzyme levels will be 
compared between chemically treated and DMSO-treated control fish.  We expect 
chemicals that accelerate liver regeneration to similarly enhance restoration of liver 
function, however it is possible that some NR pathway compounds may simply induce 
hyperplasia of non-functional cells.  Such results would indicate that these compounds 
are responsible for proliferation of cells that either are not specified hepatocytes or biliary 
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cells, or are hepatocytes or biliary cells but simply not functional.  These possibilities can 
be assessed by histology and ISH for progenitor (hhex, prox1), hepatocyte (lfabp, 
transferrin), and biliary markers (ck19).  These experiments will demonstrate whether 
modulation of NR signaling affects liver function in addition to liver regeneration. 
 
Alternative approaches 
            It is possible that surgical resections don’t recapitulate liver trauma associated 
with human liver disease or cancer, therefore lessening the potential therapeutic utility of 
our studies.  To determine whether NR pathway compounds affect other forms of liver 
injury, we can also use an acetominophen-based toxicity model developed by Drs. 
Wolfram Goessling and Leonard Zon (North et al., 2010).  Liver injury can be induced in 
adult zebrafish prior to or concomitant with chemical exposure, after which liver 
regeneration can be assessed by the parameters described above.  It will also be 
informative to treat unresected fish with RA or E2-related compounds to determine 
whether NR signaling works similarly during normal liver growth and injury repair.  We 
can also employ a more quantitative approach to assess the effect of chemical 
treatments on cell proliferation and number during regeneration by performing chemical 
exposures on lfabp:GFP reporter fish, which will allow hepatocyte number and BrdU 
incorporation or TUNEL staining to be quantified by FACS.  These assays will bolster 
and broaden our evidence demonstrating that NR signaling influences adult liver 
regeneration.  
 
ESTROGEN AND LIVER CANCER 
There is strong clinical correlation between estrogen exposure and cancer 
(Giannitrapani et al., 2006; Harris and Waring, 2012; Laronda et al., 2012), so we will 
investigate the effect of estrogen exposure on hepatic tumor formation and progression 
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in adult zebrafish.  First, we will assess the impact of long-term embryonic and larval 
estrogen exposure on adult liver histology.  We will expose zebrafish biweekly to E2 and 
selected xenoestrogens from 3 days to 6 weeks old, then allow the fish to mature to 
adulthood.  Estrogen and DMSO-exposed control animals will be sacrificed at 3, 6, and 
12 months of age, and livers will be examined for any histological changes.  We will 
perform trichrome and oil red O staining to detect fibrosis and steatosis, respectively, 
and look for evidence of hepatic dysplasia or cancer.  At each time point, we will 
euthanize an equal number of male and female fish to delineate any gender-specific 
effects.   
It is possible that estrogen exposure alone will not be sufficient to induce hepatic 
tumor formation, so we will also perform the above experiment using APC +/- fish 
(Hurlstone et al., 2003) and dimethylbenzanthracene (DMBA), a known liver carcinogen 
(Spitsbergen et al., 2000).  In addition to regular estrogen exposure, juvenile fish will be 
exposed to DMBA at 3 and 4 weeks old to accelerate and increase the frequency of 
tumor formation.  Fish will be sacrificed beginning at 3 months of age, and livers will be 
examined for tumor development.  We will determine whether the expression of estrogen 
pathway members such as aromatase and ESRs is altered in cancerous livers as well as 
investigate whether expression of particular pathway components correlates with lesion 
subtypes (hepatocellular carcinoma, cholangiocarcinoma, combination tumors, 
dysplastic nodules).   It has been reported that ESR expression is increased in livers 
with cirrhosis or hepatocellular carcinoma (HCC), so we anticipate similar 
overexpression phenotypes in our fish studies.  We will perform immunohistochemistry 
for cell cycle markers (Cyclin D1, PCNA, Phospho-H3) to examine the proliferation state 
of liver samples and nuclear β-catenin to assess Wnt activation, commonly associated 
with HCC.   We predict overlap between areas of enhanced estrogen and Wnt activity in 
hepatic tumor samples.  Finally, in addition to exploring the effect of estrogenic 
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compounds on tumor incidence, we will also expose tumorogenic fish to estrogen 
pathway inhibitors to determine whether these compounds alter tumor progression.  Wild 
type and APC +/- fish will be exposed to DMBA as above then treated with fulvestrant or 
tamoxifen and sacrificed at regular intervals to assess cancer incidence and 
progression.  Experiments may require that we follow individual fish over time to assess 
disease progression or regression, so we will also employ ultrasound biomicroscopy on 
live zebrafish, a method previously developed by the laboratory (Goessling et al., 2007).  
The above experiments can also be performed in lfabp:GFP or ERE:GFP transgenic 
reporter lines to facilitate visualization of the liver and localized estrogen pathway 
activation.  These studies will uncover the impact of estrogen exposure during 
embryonic, larval, and adult stages on adult liver homeostasis and enhance our 
understanding of the impact of estrogen signaling on hepatic pathologies. 
 
METHODS 
Larval chemical exposures 
Lfabp:dsRed transgenic reporter zebrafish larvae were exposed to 1 µM E2 and 10 µM 
fulvestrant from 120-144 hpf, and liver development was assessed by live fluorescence 
microscopy.  Stock solutions were diluted in E3 embryo water, and control embryos were 
treated with 0.1% DMSO. 
 
Flow cytometry analysis 
Lfabp:GFP fluorescent embryos were exposed to estrogen pathway compounds, whole 
embryos were manually dissociated in 0.9x PBS, and %GFP+ cells were determined by 
flow cytometric analysis. ≥20,000 cells were analyzed per embryo, and ≥5 embryos were 
analyzed for each chemical treatment using FlowJo software. 
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ChIP-seq 
Esr2a and esr2b were cloned from embryonic zebrafish cDNA, and Myc-tagged Esr 
constructs were created using Gateway cloning technology (Life Technologies).  1,500 
embryos were injected with 1 nl of 25 ng/µl esr2a-myc or esr2b-myc mRNA at the 1-cell 
stage for each timepoint.  Chromatin immunoprecipitation was carried out as described 
previously (Lee et al., 2006; Xu et al., 2012) using whole embryo lysates and magnetic 
beads loaded with anti-Myc antibody (Abcam).  Purified DNA was prepared using the 
Illumina Genomic DNA kit and sequenced on the Illumina Genome Analyzer.   
 
1/3 partial hepatectomy 
Adult wild type fish (>3 months old) were anesthetized with tricaine, and 1/3 partial 
hepatectomy was performed using brightfield imaging as previously described 
(Goessling et al., 2008).  An incision was made on the abdomen just posterior to the 
heart with microdissection scissors, and forceps were used to resect the exposed left 
liver lobe.  Fish were allowed to recover in system water for 6 hours and then exposed to 
chemical compounds or DMSO for 18 hours.  Following chemical treatment, fish were 
placed in fresh water for an additional 48 hours.  Three days after the time of resection, 
fish were euthanized, and livers were dissected for analysis.  The ratio of total liver lobe 
length to regrowing lobe length (lobe:remnant) is used to provide a normalized measure 
of regenerative capacity and was calculated for all control and chemically-treated fish. 
 
ATTRIBUTIONS 
Partial hepatectomy:  Maija Garnaas (retinoic acid) and Claire Cutting (estrogen).  Larval 
estrogen exposures: Maija Garnaas and Claire Cutting.  ChIP-seq: Maija Garnaas and 
Kristen Alexa. 
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CHAPTER 5 
 
 
Concluding Discussion 
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SUMMARY  
 The liver is a vital organ responsible for a myriad of functions including hormone 
and bile secretion, detoxification, and metabolic regulation.  Liver and overall embryonic 
development must occur in tandem, particularly because an organism’s ability to grow is 
directly correlated with its capacity to process nutrients and avoid exposure to harmful 
toxins.  Moreover, in mammals the liver is a site of early hematopoieisis.  As such, any 
aberrations in liver development may directly impact successful establishment of 
circulation, reducing the likelihood of embryo survival.  Similarly, because the liver 
governs many normal physiological processes throughout an organism’s life, liver 
diseases such as cirrhosis, steatosis, and cancer result in high rates of morbidity and 
mortality.  Liver disease is the fourth leading cause of death in the United States in 
middle-aged adults (Si-Tayeb et al., 2010).  When a significant portion of the liver is 
irreparably damaged and hepatic function is lost, liver failure ensues, and patients 
require immediate intensive care without which the mortality rate reaches 60-90% 
(Larson 2008; Lee and Seremba, 2008). 
 Understanding the genetic programs driving liver development and homeostasis 
will yield insight into the mechanisms fundamental to hepatogenesis and liver disease.  
Additionally, knowledge gained from investigations of embryonic liver development can 
be directly applied to the burgeoning field of stem cell biology.  The discrepancy between 
the number of livers required for transplant and their availability necessitates that 
alternative approaches be taken to create replacement tissues.  Studies identifying 
developmental genes that control hepatic specification and differentiation will 
immediately impact research aiming to create viable and functional hepatocytes from 
pluripotent stem cells.  In the same vein, the prospect of in situ regeneration of damaged 
adult tissues will undoubtedly be aided by the characterization of hepatic developmental 
factors. 
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 Harnessing the power of zebrafish genetics, I have expanded our understanding 
of two nuclear receptor signaling pathways in embryonic liver development and outlined 
future investigations to characterize these developmental signals in the adult in normal, 
cancerous, and regenerative states.  In Chapter 2, I elucidated the role of a number of 
retinoic acid (RA) signaling pathway factors including RA-synthesizing Raldh enzymes 
and individual RA receptors (RARs) during hepatogenesis.  I demonstrated a unique 
function for Rargb in governing left-right asymmetry of the liver and adjacent tissues and 
identified its mechanism of regulation via Bmp signaling.  I also situated RA signaling in 
the context of human disease, as rargb knockdown phenotypes closely resemble the 
human heterotaxic syndrome right atrial isomerism (Ivemark Syndrome).  In Chapter 3, I 
characterized the function of estrogen signaling during hepatic differentiation.  I 
discovered that both naturally occuring and environmental estrogens negatively impact 
liver growth, delaying hepatocyte differentation, and demonstrated that the Esr2 receptor 
isoform mediates this effect.  Importantly, I also determined that estrogen’s effect on liver 
development is conserved in mouse and humans, highlighting the applicability of our 
zebrafish studies to higher vertebrate species and making them directly relevant to 
human physiology. 
 
FINAL REMARKS 
 Development is comprised of a complex network of hundreds of regulatory 
pathways, which themselves are inherently complicated.  Why?  Considering one  
organ – the liver – there are a series of events that must occur in highly regulated 
fashion for a liver, and ultimatey an embryo, to come to be.  First, hepatic progenitors 
must be specified in the right place at the right time.  A number of organs arise from the 
foregut endoderm, so whether a cell becomes liver or something else, such as the 
pancreas, necessitates intricate coordination.  Second, liver differentiation and growth 
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must be coincident with other organs and the embryo as a whole.  Third, mature hepatic 
cells must know when and to what extent they should begin performing their endocrine, 
exocrine, and metabolic functions.  These requirements, their essential nature, and the 
fact that each developmental program does not occur in a vacuum but within the context 
of the whole organism, justify development’s complexity.  And perhaps most importantly, 
because embryo survival is the ultimate goal of development, having redundancy or 
molecular fail safes is the most effective way to achieve this end. 
 In terms of initiating liver development, it is clear that RA signaling plays an 
integral role in determining whether and where hepatic cells are specified.  Loss of RA 
signaling by globally repressing RA synthesis or downstream signal transduction results 
in small or no livers.  Interestingly, we found that whether specification occurs and its 
spatial regulation are each governed by a subset of RARs in zebrafish – Raraa, Rarab, 
and Rarga regulate the "if", and Rargb regulates the "where".  Our results suggest that 
there is a hierarchy of RAR function during hepatogenesis.  Specifically, the first three 
receptors must be required prior to Rargb in order for liver specification to occur and in 
the appropriate location.  If an embryo does not express Raraa, Rarab, or Rarga, it will 
not specify liver cells, in which case Rargb expression is immaterial as there are no 
hepatic progenitors to be localized to either side of the midline in the first place.  This 
concept is corroborated by our data demonstrating that knockdown of all RARs in 
combination results only in very small or absent livers but not bilateral livers.  Finally, the 
fact that three receptors govern hepatic specification while just one governs hepatic 
position is a seemingly evolutionarily advantageous allocation; that is, an embryo is 
better off creating an organ in the wrong location than having no organ at all. 
 Following specification, subsequent hepatic differentiation allows the developing 
organ to begin perfoming its requisite functions.  We have demonstrated that estrogen 
signaling functions during this step of hepatogenesis: exogenous estrogen exposure 
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negatively impacts liver differentiation, and changing levels of endogenous estrogen 
signaling in the embryo coincide with the timing of differentiation.  Specifically, it appears 
as though the embryo takes advantage of an inherent decline in endogenous estrogen 
levels to allow liver differentiation to proceed.  The liver develops in concert with the rest 
of the embryo, and every organ must be specified at the correct moment to ensure 
proper body plan organization, tissue connections, and efficiency of function.  It is 
tempting to speculate that the embryo employs estrogen to delay hepatic differentiation 
to prevent unwanted energy expenditure before liver function, carried out by 
differentiated hepatocytes and bile duct cells, is required.  For instance, the 
hematopoietic system originates prior to initiation of liver function.  This makes 
developmental sense, since only after the embryo establishes its hematopoietic system 
and blood flow is initiated can the liver act to detoxify it.  Similarly, it would be inefficient 
to commence bile secretion, an exocrine function of the liver, before the embryo has 
exhausted its yolk supply and digestion of externally supplied nutrition has begun. 
Retinoic acid and estrogen signaling are just two of the countless signaling 
pathways that regulate liver development.  Each pathway is elaborate and impacts 
different aspects of liver development, as do individual components within each 
pathway, underscoring the complexity of hepatogenesis.  Certainly, RA and estrogen 
signaling are not the only mechanisms by which liver specification, laterality, and 
differentiation are regulated, but this fact further emphasizes the intricate nature of 
embryonic development.  What the embryo loses in efficiency by employing a multitude 
of overlapping, if not completely redundant, signaling pathways, it gains in ensuring its 
survival – the ultimate goal of development. 
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INTRODUCTION 
 In collaboration with the NHLBI/Framingham Heart Study and the CARe 
consortium, I investigated the developmental importance of genes implicated in human 
chronic kidney disease (CKD) by genome-wide association studies (GWAS).  To gain 
insight into the functional implications of associated loci, I knocked down corresponding 
genes in the zebrafish and assessed kidney gene expression, structure, and function.  
Single nucleotide polymorphisms (SNPs) in the human genes MPPED2 and CASP9 
were correlated with defective estimated glomerular filtration rate (eGFR), and I found 
that loss of these genes in zebrafish results in aberrant glomerular gene expression and 
filtration capacity.  The following report demonstrates a role for mpped2 and casp9 in 
kidney development, indicating that cross-species modeling in zebrafish is feasible for 
genes associated with chronic human disease.  
 
RELATED PROJECTS 
 The following manuscripts are examples of additional studies in which zebrafish 
were used to perform functional assessments of loci associated with human CKD: 
 
Liu, C.*, Garnaas, M.*, Tin, A., Kottgen, A., Franceschini, N. et al. (2011). Genetic 
association for renal traits among participants of African ancestry reveals new loci for 
renal function. PLoS Genetics 7(9): e1002264. *Equal contribution. 
 
Gorski, M.*, Tin, A.*, Garnaas, M.K.*, McMahon, G. M., Chu, A. Y. et al. (2013).  
Genome-wide association study reveals two novel loci associated with kidney function 
decline: the CKDGen Corsortium. Submitted, PLoS Genetics.  *Equal contribution. 
 
McMahon, G. M., Olden, M., Garnaas, M. K., Yang, Q., Hwang, S., Larson, M. G., 
CKDGen Corsortium, Goessling, W., and Fox, C.S. (2013). Sequencing of LRP2 
Reveals Multiple Rare Variants associated with Urinary Trefoil Factor-3. Submitted, 
JASN.  
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Figure S8.  Ddx1 knockdown does not affect kidney gene expression.  
(A–E) Uninjected control embryos show normal kidney development as demonstrated by 
in situ hybridization for the renal markers pax2a (A, B), nephrin (C), slc20a1a (D) and 
slc12a3 (E).  (F–J) Ddx1 morpholino (MO)-injected embryos do not show significant 
changes in renal marker expression.  (K) Number of observed abnormalities per number 
of embryos examined at 400 uM MO injection for renal gene expression analysis. 
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Figure S9.  Casp9 and mpped2 knockdown embryos are more susceptible to 
gentamicin-induced kidney injury.  
Compared to control embryos (A), casp9 and mpped2 knockdown embryos develop 
edema at 103 hpf (C, E), suggestive of a renal defect.  When injected with gentamicin, a 
nephrotoxin that reproducibly induces edema in control embryos (B), mpped2 and casp9 
knockdown embryos develop edema earlier, more frequently, and in a more severe 
fashion (D, F).  Whereas control embryos primarily develop cardiac edema, mpped2 and 
casp9 knockdown embryos display cardiac (arrowhead), ocular (black arrow), and 
visceral (white arrow) edema, demonstrating that mpped2 and casp9 knockdown 
predisposes embryos to kidney injury. (G) Quantification of edema prevalence in control, 
mpped2, and casp9 knockdown embryos 2, 22, and 55 hours post-gentamicin injection 
(hpi).  These numbers are presented graphically in Figure 2X. 
	  
